Psychological first aid: Emergency care for terrorism and disaster survivors

Article Type
Changed
Tue, 12/11/2018 - 15:10
Display Headline
Psychological first aid: Emergency care for terrorism and disaster survivors

The night started like any other for Dr. Z. Kids in bed (too late) by 10:30, dog out by 11, fell asleep reading journal by 11:15. Sirens jolt her out of a solid stage 4. Her eyes widen, pulse quickens, mouth dries as she follows the glow of the TV into the living room. On TV, fire frames shots of tearful faces, body bags, and firefighters in protective suits. She catches the announcer’s voice: “…explosion at City Power and Light nuclear facility at 3:10 AM today. Fifty-five are known dead, and thousands are being told to evacuate. The blast’s cause is unknown, but terrorism is suspected.”

As her numbness slowly ebbs, Dr. Z’s questions rise insistently. How can I help the survivors? My patients? My children? What if the media call me? How could I have been better prepared for this?

Disaster shakes us to our human and biological core. More than any other clinical encounter, it reminds us that psychiatrists share the vulnerabilities of those we seek to help. Yet it also reminds us that even simple concepts and interventions can mobilize the healing process.

Are you ready to provide emergency psychiatric care following a disaster in your community—be it a nuclear accident, tornado, airplane crash, or terrorist act? Here is evidence—some counterintuitive—that can help you prepare.

Table 1

‘Psychological first aid’ for disaster survivors

Re-create sense of safety
  • Provide for basic needs (food, clothing, medical care)
  • Ensure that survivors are safe and protected from reminders of the event
  • Protect them from onlookers and the media
  • Help them establish a “personal space” and preserve privacy and modesty
Encourage social support
  • Help survivors connect with family and friends (most urgently, children with parents)
  • Educate family and friends about survivors’ normal reactions and how they can help
Re-establish sense of efficacy
  • Give survivors accurate, simple information about plans and events
  • Allow survivors to discuss events and feelings, but do not probe
  • Encourage them to re-establish normal routines and roles when possible
  • Help resolve practical problems, such as getting transportation or relief vouchers
  • Discuss self-care and strategies to reduce anxiety, such as grounding and relaxation techniques
  • Encourage survivors to support and assist others

Disaster’s psychobiology

Human reactions to disaster are often conceptualized as the mammalian survival response: flight, fight, and fright (freezing). In most cases, these reactions are adaptive and dissipate after safety is restored. Posttraumatic stress disorder (PTSD) develops in about 5% of natural disaster victims and 33% of mass shooting victims.1

Responses that do go awry appear to be associated with abnormally low cortisol and persistent adrenergic activation, leading to sensitization of the fear response.2 Reminders of trauma or persistent stressors—such as pain, problems with finances or housing, or bereavement—may exacerbate sensitization. On the other hand, preclinical studies suggest that social support3,4 and active coping5 mitigate physiologic stress responses, confirming numerous clinical observations that associate lack of social support and avoidant coping with eventual PTSD development.

Three basics. Just as our emergency medicine colleagues must often revert to life-support basics, we must remind ourselves of biology’s three basics for psychic resilience:

  • safety (including—as much as possible—protection from reminders of trauma and ongoing stress)
  • meaningful social connection
  • re-establishing a sense of efficacy to overcome helplessness (Table 1).

Like the stress response, these protective factors seem hard-wired into our biological make-up. They form the foundation for all phases of disaster psychiatry interventions, from planning to immediate interventions through longterm follow-up.

Disaster planning

As a mental health professional, plan to operate within established disaster plans and agencies, not only for the sake of efficiency but also because structure and support are paramount in disaster situations. Check with the American Psychiatric Association’s local branch to determine if a disaster mental health plan exists. If not, explore how to work directly with local American Red Cross chapters and hospitals, which recruit personnel for the Disaster Medical Assistance Teams mobilized by the public health service.

Table 2

Normal reactions to disaster for adults and children

All ages
EmotionalShock, fear, grief, anger, guilt, shame, helplessness, hopelessness, numbness, emptiness Decreased ability to feel interest, pleasure, love
CognitiveConfusion, disorientation, indecisiveness, worry, shortened attention span, poor concentration, memory difficulties, unwanted memories, self-blame
PhysicalTension, fatigue, edginess, insomnia, generalized aches and pains, startling easily, rapid heartbeat, nausea, decreased appetite and sex drive
InterpersonalDifficulties being intimate, being over-controlling, feeling rejected or abandoned
Children’s age-specific disaster responses
PreschoolSeparation fears, regression, fussiness, temper tantrums, somatization Sleep disturbances including nightmares, somnambulism, night terrors
School-ageMay still have the above, as well as excessive guilt and worries about others’ safety, poor concentration and loss of school performance, repetitious re-telling or play related to trauma
AdolescentDepression, acting out, wish for revenge, sleeping and eating disturbances, altered view of the future
 

 

Immediate disaster mental health plans vary in detail according to local needs and resources but should at least address:

  • providing on-site interventions
  • disseminating information about responses to trauma
  • identifying and publicizing local mental health resources.

Immediate interventions

Immediately following a disaster, psychiatrists are frequently asked to assist with on-site crisis and medical interventions, evaluate survivors with unusual or intense reactions, and provide public education about psychological reactions to disaster.

On-site response. All responders, regardless of discipline, should provide disaster survivors with “psychological first aid,” which is directed at reestablishing safety, connection, and efficacy. Basic crisis intervention principles are useful when support and reassurance are not enough.6

For example, relaxation exercises can reduce anxiety and improve sleep. Use focused, structured relaxation tools—such as progressive muscle relaxation and breathing training—as unstructured exercises can exacerbate dissociation and re-experiencing. Grounding techniques, by which survivors learn to focus all senses on immediate surroundings, often alleviate dissociation and flashbacks.

Care for children. Because children’s reactions to disaster greatly depend on their caregivers’ responses (social referencing), focus acute interventions for children on:

  • re-connecting them with their families
  • reducing caregivers’ distress
  • educating caregivers about providing age appropriate information and support (see Related resources).

Medical care. As physicians, psychiatrists may be called upon to intervene medically. Although it is generally advisable to stay within our usual practice, medical personnel may be in short supply. Fortunately, Good Samaritan laws exist in every state, and the potential for a successful malpractice suit against a physician responding in a disaster is almost zero, unless the physician’s performance is grossly negligent (such as moving the neck of a patient with obvious head or neck injuries).7

Principles regarding informed consent and right to refuse treatment—along with the usual exceptions—apply during disasters.

Evaluating survivors in shelters and hospitals requires knowing the normal and abnormal responses to disaster, being able to differentially diagnose changes in mental status, and understanding risk factors for trauma’s psychiatric sequelae. Aside from PTSD, trauma’s long-term effects include other anxiety disorders, depression, substance abuse, and eating disorders. In addition to the usual components of a psychiatric evaluation, assessments must address event-related factors such as proximity to the disaster, loss of significant others or property, physical injuries, immediate needs, and social support.8

Normal stress reactions. Frequently described as “a normal response to an abnormal situation,” the normal stress reaction is multidimensional and depends on the person’s developmental level (Table 2). About 10% to 25% of survivors experience intense affect and dissociation, whereas a similar number may appear unusually calm.

Interventions beyond the“first aid” described above are not usually needed unless individuals:

  • are a danger to themselves or others
  • are psychotic
  • have no social supports
  • cannot perform tasks necessary for self-care and to begin the recovery process.

Always re-assess when there is any question about a survivor’s immediate reaction to trauma.

In DSM-IV-TR’s trauma-related diagnoses, the symptom clusters often do not capture many disaster survivors’ subjective experience: the shattering of fundamental beliefs regarding themselves (invulnerability), the world (predictability, safety), and others (trust, benevolence).9 By empathizing with these responses, you can help survivors feel less isolated and estranged.

Differential diagnosis. Survivors’ mental status changes may be manifestations of the stress response, but they also may represent:

  • exacerbations of pre-existing psychiatric or general medical conditions
  • hypoxemia, hypovolemia, or CNS trauma from physical injury
  • responses to medications used for resuscitation or pain control, such as atropine, epinephrine, lidocaine, or morphine.

Effects of bioterrorism agents must also be considered. For example, organophosphorus compounds such as the nerve agents sarin and soman can cause impaired concentration, depression, and anxiety. Anthrax can cause rapidly progressing meningitis.10 Delirium must be differentiated from dissociation; patients with dissociation can be re-oriented, and changes will resolve with time rather than fluctuate.11

Psychopathology risk factors. Multiple studies have addressed risk factors for post-disaster psychiatric sequelae (usually PTSD). In general, risk increases with repeated trauma exposure (including TV viewing), prior trauma, lack of social support, injury, pre-existing psychiatric problems, traumatic bereavement (having witnessed the violent death of a loved one), avoidant coping, and having strong negative beliefs about the meanings of normal stress reactions such as tearfulness, anxiety, and insomnia.

Because a recent meta-analysis supports these observations,12 follow-up evaluation for signs of PTSD is recommended for:

  • survivors with one or more of the risk factors discussed above
  • vulnerable groups such as rescue workers, children, and dependent individuals
  • survivors whose symptoms persist after 2 months.13

Decompensation immediately after a disaster seems to be the exception for psychiatric patients, despite their longer-term vulnerability. One psychiatrist who in 1989 survived Hurricane Hugo—the most intense storm to strike the Mid-Atlantic region in 100 years—noted that demand for inpatient psychiatric services did not increase in the storm’s aftermath. The only patient calls she received were inquiries about her own physical safety.14

 

 

Caregivers and rescue workers—including psychi-atrists—are also disaster survivors, and you need to tend to your needs for safety and support. Consult frequently with colleagues within and outside the disaster area, as much for support as for information and guidance.15 Remember also that rescue workers are occasionally targets for victims’ rage at their circumstances. Anticipating and explaining this displacement reduces its toxicity.

Using medications

Uses psychotropics judiciously in the first 48 hours of trauma. Medication effects may interfere with neurologic assessment of the injured, and monitoring and follow-up may not be possible.

However, drug therapy should start quickly when survivors are acutely psychotic or their behavior endangers themselves, others, or the milieu. Medications usually include a fast-acting benzodiazepine and/or an antipsychotic, as described in guidelines for managing agitation.16 Always provide structure and supervision for medicated patients.

No guidelines exist for using medications to manage distressing—but less-severe—acute stress-related symptoms. Some experts advocate using adrenergic antagonists such as clonidine, guanfacine, and beta blockers to reduce excessive arousal. These drugs have not been adequately studied in this setting, however, and may harm those with cardiovascular instability from preexisting conditions or injuries.

Table 3

Psychoeducation: Simple messages for workers and trauma survivors

Get adequate rest, food, sleep
Avoid exposure to trauma cues, including TV images
Seek support from loved ones and peers
Talk about events and feelings only if this feels comfortable and helpful
Return to normal routine as much as possible
Take action to rebuild, but at a reasonable pace
Reach out to others who may need assistance
Get help:
  • immediately for abnormal reactions (psychosis, suicidality, risky behavior including substance abuse)
  • if normal reactions (insomnia, anxiety, mild dissociation) persist beyond 2 months
  • if at high risk for persistent reaction (bereaved, injured, prior trauma or psychiatric disorder, no social support)

Short-term (<1 week) benzodiazepine use for panic symptoms and severe insomnia is acceptable, but longer-term use may increase PTSD risk.17 A selective serotonin reuptake inhibitor may help individuals with pre-existing PTSD or depression, if you can arrange follow-up.

In the aftermath

‘Debriefing.’ Critical incident stress debriefing (CISD) is a structured, one-session group intervention in which survivors’ experiences and emotional reactions are discussed and education and follow-up recommendations are provided. Developed by Mitchell in 1983,18 CISD was widely used until systematic evaluations revealed that it did not alleviate psychological distress or prevent PTSD.19

Table 4

How to interact with news media during and after a disaster

For organizations
Identify a spokesperson with media experience beforehand
Ensure that the spokesperson is well-informed about all aspects of the disaster
For spokespersons
Always
  • Reply immediately to news media requests; find out the reporter’s deadline and refer the caller if you cannot meet it
  • Clearly identify yourself and the organization you represent
  • Understand what the reporter needs—what’s “behind the story”
  • Use simple, declarative sentences; avoid medical jargon
  • Emphasize one or two points
  • Be accurate and honest but use a positive, hopeful frame
  • On TV, look at the interviewer, not the camera
Never
  • Speak off the record
  • Discuss individual cases
  • Speculate on diagnosis or treatment for someone you have not examined (such as a terrorist leader)

Thus, although survivor meetings may provide information, education, screening, and support, avoid detailed discussions of events and emotions. Any meetings should be conducted by mental health clinicians and should not be mandatory. Reserve the term “debriefing” for operational reviews by rescue personnel.20

Public education. Educate survivors, rescue workers, health care providers, teachers, and relief agency workers. Provide concise, simple messages as suggested in Table 3. News media provide our most effective means of reaching out to survivors, which is why having a pre-existing relationship is so important. Some guidelines for working with the media are presented in Table 4.

Outreach. Numerous educational resources are available for survivors and their caregivers (see Related resources). Other potentially useful outreach tools include:

  • meetings with teachers’ organizations
  • continuing medical education activities for primary care providers
  • telephone hot lines.

Legal and ethical issues

Disaster scenes are chaotic and informal, and professionals must be flexible, often providing general support and information rather than specific clinical interventions. However, it is important in each encounter to decide whether a patient-physician relationship has begun.

As a general rule, a physician-patient relationship is established whenever diagnosis or treatment is discussed. Once that happens, briefly document:

  • signs and symptoms
  • working diagnosis
  • suicide or violence potential
  • treatment and/or follow-up plans.

Confidentiality may be difficult to preserve in chaotic situations involving workers from many agencies. Even in disasters, however, you must obtain permission before sharing information unless the individual’s situation is emergent.

Table 5

 

 

Keys to effective disaster psychiatry

Be prepared
  • Contact your local American Psychiatric Association district branch or American Red Cross chapter to learn about existing mental health disaster plans
  • Remember the three basics of psychic resiliency: safety, support, and efficacy
  • Know your place, ask for help, and use existing resources
Care for survivors
  • Your presence alone may be healing
  • Assess thoroughly; symptoms may be related to medical issues or pre-existing conditions, not just stress response
  • Do no harm; avoid psychological debriefing interventions and unnecessary medications
  • Follow up with survivors who exhibit risk factors or symptoms persisting >2 months
  • Consider trauma-focused CBT for survivors with acute stress disorder
Care for yourself
  • As a survivor, tend to your own safety and self-care needs
  • Consult frequently with colleagues within and outside the disaster area for support, information, and guidance

Long-term interventions

Longer-term disaster interventions include continued outreach and education and needed follow-up services. Existing structures may provide effective follow-up, but additional resources are often needed.

Federal programs. Following a presidentialdeclared disaster, the Federal Emergency Management Agency (FEMA) provides funding for crisis counseling. Programs are typically funded for 9 to 15 months and administered through the emergency services and disaster relief branch of the Substance Abuse and Mental Health Services Administration (SAMHSA) and community mental health organizations. Examples include Project Heartland following the 1995 Oklahoma City federal building bombing and Project COPE following California’s 1989 Loma Prieta earthquake.

Cognitive-behavioral therapy. For adult survivors with acute stress disorder, specific cognitive-behavioral therapy (CBT) provided by trained therapists may prevent PTSD and other trauma sequelae, such as depression.21 CBT interventions may begin as early as 2 weeks after trauma and focus sequentially on anxiety management, cognitive restructuring, imaginal exposure followed by in vivo exposure, and relapse prevention.

Three controlled trials found 6-month PTSD rates of 14% to 20% among acute stress disorder patients treated with CBT, compared with 58% to 67% with supportive counseling.22-24 Although studies of interventions immediately following trauma are lacking, trauma-focused CBT is also recommended for children.25 Evidence-based treatments for PTSD are discussed in detail elsewhere.26

Not unprepared after all

With some reflection, Dr. Z realized she had the tools to help her community. Her feelings of helplessness receded as she envisioned how she could help survivors understand their experiences, re-create a sense of safety, restore important connections to loved ones, and begin to rebuild their lives (Table 5).

Related resources

For clinicians

  • Young BH, Ford JD, Ruzek JI, et al. Disaster mental health: a guidebook for clinicians and administrators. Washington, DC: National Center for Post-Traumatic Stress Disorder, 1998. http://ncptsd.org/publications/disaster/index.html
  • Hillman JL. Crisis intervention and trauma: new approaches to evidence-based practice. New York: Kluwer Academic/Plenum Publishers, 2002.
  • Office of the Surgeon General Web site on medical aspects of nuclear, biological, and chemical warfare. http://www.nbc-med.org

For survivors and clinicians

Drug brand names

  • Clonidine • Catapres
  • Guanfacine • Tenex

Disclosure

The authors report no financial relationship with any company whose products are mentioned in this article or with manufacturers of competing products.

References

1. Effects of traumatic stress in a disaster situation. Washington, DC: National Center for Post-Traumatic Stress Disorder. Department of Veterans Affairs, September 12, 2001 (Accessed March 31, 2004 at http://www.ncptsd.org/facts/disasters/fs_effects_disaster.html).

2. Yehuda R, McFarlane AC, Shalev AY. Predicting the development of post-traumatic stress disorder from the acute response to a traumatic event. Biol Psychiatry 1998;44:1305-13.

3. Levine S, Lyons DM, Schatzberg AF. Psychobiological consequences of social relationships. Ann NY Acad Sci 1997;807:210-18.

4. Uchino BN, Garvey TS. The availability of social support reduces cardiovascular reactivity to acute psychological stress. J Behav Med 1997;20:15-27.

5. LeDoux JE, Gorman JM. A call to action: overcoming anxiety through active coping. Am J Psychiatry 2001;158:1953-5.

6. Hillman JL. Crisis intervention and trauma: new approaches to evidence-based practice. New York: Kluwer Academic/Plenum Publishers, 2002.

7. Daniels G. Good Samaritan acts. Emerg Med Clin North Am 1999;17:491-504.

8. Mental-health intervention for disasters. Washington, DC: National Center for Post-Traumatic Stress Disorder, Department of Veterans Affairs, Sept. 12, 2001. (Accessed March 31, 2004 at http://www.ncptsd.org/facts/disasters/fs_treatment_disaster.html.)

9. Difede J, Apfeldorf WJ, Cloitre M, et al. Acute psychiatric responses to the explosion at the World Trade Center: a case series. J Nerv Ment Dis 1997;185:519-22.

10. DiGiovanni C. Domestic terrorism with chemical or biological agents: psychiatric aspects. Am J Psychiatry 1999;156:1500-5.

11. Rundle JR. Psychiatric issues in medical-surgical disaster casualties: consultation-liaison approach. Psychiatr Q 2000;71:245-58.

12. Brewin CR, Andrews B, Valentine JD. Meta-analysis of risk factors for post-traumatic stress disorder in trauma-exposed adults. J Consult Clin Psychol 2000;68:748-66.

13. Mental health and mass violence: evidence-based early psychological intervention for victims/survivors of mass violence. Washington, DC: National Institute of Mental Health, Nov. 1, 2002 (Accessed Oct. 29, 2003 at http://www.nimh.nih.gov/research/massviolence.pdf.)

14. Austin LS. Organizing a disaster response program in one’s home community. In: Austin LS (ed). Responding to disaster: a guide for mental health professionals. Washington, DC: American Psychiatric Publishing, 1992;53-68.

15. Rousseau AW. Notes from Oklahoma City’s recovery. In: Hall RCW, Norwood AE (eds). Disaster psychiatry handbook. Washington, DC: American Psychiatric Association Committee on Psychiatric Dimensions of Disaster, undated:3-11. (Accessed Oct. 29, 2003 at http://www.psych.org/disasterpsych/pdfs/apadisasterhandbk.pdf.)

16. Yildiz A, Sachs GS, Turgay A. Pharmacological management of agitation in emergency settings. Emerg Med J 2003;20:339-46.

17. Gelpin E, Bonne O, Peri T, et al. Treatment of recent trauma survivors with benzodiazepines: a prospective study. J Clin Psychiatry 1996;57:390-4.

18. Mitchell JT. When disaster strikes. J Em Med Serv 1983;8:36-9.

19. Rose S, Bisson J, Wessely S. Psychological debriefing for preventing posttraumatic stress disorder (PTSD). Cochrane Database Syst Rev 2002;(2):CD000560.-

20. Black J. Forming the libidinal cocoon: the Dallas airplane crashes, the Guadalupe river drownings, and Hurricane Hugo in the Virgin Islands. In: Austin LS (ed). Responding to disaster: a guide for mental health professionals. Washington DC: American Psychiatric Publishing, 1992;169:84.-

21. Ehlers A, Clark DM. Early psychological interventions for adult survivors of trauma: a review. Biol Psychiatry 2003;53:817-26.

22. Bryant RA, Moulds M, Guthrie R, Nixon RD. Treating acute stress disorder following mild traumatic brain injury. Am J Psychiatry 2003;160:585-7.

23. Bryant RA, Sackville T, Dang ST, et al. Treating acute stress disorder: an evaluation of cognitive behavior therapy and supportive counseling techniques. Am J Psychiatry 1999;156:1780-6.

24. Bryant RA, Harvey AG, Dang ST, et al. Treatment of acute stress disorder: a comparison of cognitive-behavioral therapy and supportive counseling. J Consult Clin Psychol 1998;66:862-6.

25. Cohen JA. Treating acute posttraumatic reactions in children and adolescents. Biol Psychiatry 2003;53:827-33.

26. Foa EB, Keane TM, Friedman MJ. Effective treatments for PTSD. New York: Guilford Press, 2000.

Article PDF
Author and Disclosure Information

Nancy L. Cloak, MD
Staff psychiatrist Portland State University Portland, OR

Pamela Edwards, MD
Assistant professor, Department of Psychiatry Oregon Health and Science University Portland

Issue
Current Psychiatry - 03(05)
Publications
Topics
Page Number
12-23
Sections
Author and Disclosure Information

Nancy L. Cloak, MD
Staff psychiatrist Portland State University Portland, OR

Pamela Edwards, MD
Assistant professor, Department of Psychiatry Oregon Health and Science University Portland

Author and Disclosure Information

Nancy L. Cloak, MD
Staff psychiatrist Portland State University Portland, OR

Pamela Edwards, MD
Assistant professor, Department of Psychiatry Oregon Health and Science University Portland

Article PDF
Article PDF

The night started like any other for Dr. Z. Kids in bed (too late) by 10:30, dog out by 11, fell asleep reading journal by 11:15. Sirens jolt her out of a solid stage 4. Her eyes widen, pulse quickens, mouth dries as she follows the glow of the TV into the living room. On TV, fire frames shots of tearful faces, body bags, and firefighters in protective suits. She catches the announcer’s voice: “…explosion at City Power and Light nuclear facility at 3:10 AM today. Fifty-five are known dead, and thousands are being told to evacuate. The blast’s cause is unknown, but terrorism is suspected.”

As her numbness slowly ebbs, Dr. Z’s questions rise insistently. How can I help the survivors? My patients? My children? What if the media call me? How could I have been better prepared for this?

Disaster shakes us to our human and biological core. More than any other clinical encounter, it reminds us that psychiatrists share the vulnerabilities of those we seek to help. Yet it also reminds us that even simple concepts and interventions can mobilize the healing process.

Are you ready to provide emergency psychiatric care following a disaster in your community—be it a nuclear accident, tornado, airplane crash, or terrorist act? Here is evidence—some counterintuitive—that can help you prepare.

Table 1

‘Psychological first aid’ for disaster survivors

Re-create sense of safety
  • Provide for basic needs (food, clothing, medical care)
  • Ensure that survivors are safe and protected from reminders of the event
  • Protect them from onlookers and the media
  • Help them establish a “personal space” and preserve privacy and modesty
Encourage social support
  • Help survivors connect with family and friends (most urgently, children with parents)
  • Educate family and friends about survivors’ normal reactions and how they can help
Re-establish sense of efficacy
  • Give survivors accurate, simple information about plans and events
  • Allow survivors to discuss events and feelings, but do not probe
  • Encourage them to re-establish normal routines and roles when possible
  • Help resolve practical problems, such as getting transportation or relief vouchers
  • Discuss self-care and strategies to reduce anxiety, such as grounding and relaxation techniques
  • Encourage survivors to support and assist others

Disaster’s psychobiology

Human reactions to disaster are often conceptualized as the mammalian survival response: flight, fight, and fright (freezing). In most cases, these reactions are adaptive and dissipate after safety is restored. Posttraumatic stress disorder (PTSD) develops in about 5% of natural disaster victims and 33% of mass shooting victims.1

Responses that do go awry appear to be associated with abnormally low cortisol and persistent adrenergic activation, leading to sensitization of the fear response.2 Reminders of trauma or persistent stressors—such as pain, problems with finances or housing, or bereavement—may exacerbate sensitization. On the other hand, preclinical studies suggest that social support3,4 and active coping5 mitigate physiologic stress responses, confirming numerous clinical observations that associate lack of social support and avoidant coping with eventual PTSD development.

Three basics. Just as our emergency medicine colleagues must often revert to life-support basics, we must remind ourselves of biology’s three basics for psychic resilience:

  • safety (including—as much as possible—protection from reminders of trauma and ongoing stress)
  • meaningful social connection
  • re-establishing a sense of efficacy to overcome helplessness (Table 1).

Like the stress response, these protective factors seem hard-wired into our biological make-up. They form the foundation for all phases of disaster psychiatry interventions, from planning to immediate interventions through longterm follow-up.

Disaster planning

As a mental health professional, plan to operate within established disaster plans and agencies, not only for the sake of efficiency but also because structure and support are paramount in disaster situations. Check with the American Psychiatric Association’s local branch to determine if a disaster mental health plan exists. If not, explore how to work directly with local American Red Cross chapters and hospitals, which recruit personnel for the Disaster Medical Assistance Teams mobilized by the public health service.

Table 2

Normal reactions to disaster for adults and children

All ages
EmotionalShock, fear, grief, anger, guilt, shame, helplessness, hopelessness, numbness, emptiness Decreased ability to feel interest, pleasure, love
CognitiveConfusion, disorientation, indecisiveness, worry, shortened attention span, poor concentration, memory difficulties, unwanted memories, self-blame
PhysicalTension, fatigue, edginess, insomnia, generalized aches and pains, startling easily, rapid heartbeat, nausea, decreased appetite and sex drive
InterpersonalDifficulties being intimate, being over-controlling, feeling rejected or abandoned
Children’s age-specific disaster responses
PreschoolSeparation fears, regression, fussiness, temper tantrums, somatization Sleep disturbances including nightmares, somnambulism, night terrors
School-ageMay still have the above, as well as excessive guilt and worries about others’ safety, poor concentration and loss of school performance, repetitious re-telling or play related to trauma
AdolescentDepression, acting out, wish for revenge, sleeping and eating disturbances, altered view of the future
 

 

Immediate disaster mental health plans vary in detail according to local needs and resources but should at least address:

  • providing on-site interventions
  • disseminating information about responses to trauma
  • identifying and publicizing local mental health resources.

Immediate interventions

Immediately following a disaster, psychiatrists are frequently asked to assist with on-site crisis and medical interventions, evaluate survivors with unusual or intense reactions, and provide public education about psychological reactions to disaster.

On-site response. All responders, regardless of discipline, should provide disaster survivors with “psychological first aid,” which is directed at reestablishing safety, connection, and efficacy. Basic crisis intervention principles are useful when support and reassurance are not enough.6

For example, relaxation exercises can reduce anxiety and improve sleep. Use focused, structured relaxation tools—such as progressive muscle relaxation and breathing training—as unstructured exercises can exacerbate dissociation and re-experiencing. Grounding techniques, by which survivors learn to focus all senses on immediate surroundings, often alleviate dissociation and flashbacks.

Care for children. Because children’s reactions to disaster greatly depend on their caregivers’ responses (social referencing), focus acute interventions for children on:

  • re-connecting them with their families
  • reducing caregivers’ distress
  • educating caregivers about providing age appropriate information and support (see Related resources).

Medical care. As physicians, psychiatrists may be called upon to intervene medically. Although it is generally advisable to stay within our usual practice, medical personnel may be in short supply. Fortunately, Good Samaritan laws exist in every state, and the potential for a successful malpractice suit against a physician responding in a disaster is almost zero, unless the physician’s performance is grossly negligent (such as moving the neck of a patient with obvious head or neck injuries).7

Principles regarding informed consent and right to refuse treatment—along with the usual exceptions—apply during disasters.

Evaluating survivors in shelters and hospitals requires knowing the normal and abnormal responses to disaster, being able to differentially diagnose changes in mental status, and understanding risk factors for trauma’s psychiatric sequelae. Aside from PTSD, trauma’s long-term effects include other anxiety disorders, depression, substance abuse, and eating disorders. In addition to the usual components of a psychiatric evaluation, assessments must address event-related factors such as proximity to the disaster, loss of significant others or property, physical injuries, immediate needs, and social support.8

Normal stress reactions. Frequently described as “a normal response to an abnormal situation,” the normal stress reaction is multidimensional and depends on the person’s developmental level (Table 2). About 10% to 25% of survivors experience intense affect and dissociation, whereas a similar number may appear unusually calm.

Interventions beyond the“first aid” described above are not usually needed unless individuals:

  • are a danger to themselves or others
  • are psychotic
  • have no social supports
  • cannot perform tasks necessary for self-care and to begin the recovery process.

Always re-assess when there is any question about a survivor’s immediate reaction to trauma.

In DSM-IV-TR’s trauma-related diagnoses, the symptom clusters often do not capture many disaster survivors’ subjective experience: the shattering of fundamental beliefs regarding themselves (invulnerability), the world (predictability, safety), and others (trust, benevolence).9 By empathizing with these responses, you can help survivors feel less isolated and estranged.

Differential diagnosis. Survivors’ mental status changes may be manifestations of the stress response, but they also may represent:

  • exacerbations of pre-existing psychiatric or general medical conditions
  • hypoxemia, hypovolemia, or CNS trauma from physical injury
  • responses to medications used for resuscitation or pain control, such as atropine, epinephrine, lidocaine, or morphine.

Effects of bioterrorism agents must also be considered. For example, organophosphorus compounds such as the nerve agents sarin and soman can cause impaired concentration, depression, and anxiety. Anthrax can cause rapidly progressing meningitis.10 Delirium must be differentiated from dissociation; patients with dissociation can be re-oriented, and changes will resolve with time rather than fluctuate.11

Psychopathology risk factors. Multiple studies have addressed risk factors for post-disaster psychiatric sequelae (usually PTSD). In general, risk increases with repeated trauma exposure (including TV viewing), prior trauma, lack of social support, injury, pre-existing psychiatric problems, traumatic bereavement (having witnessed the violent death of a loved one), avoidant coping, and having strong negative beliefs about the meanings of normal stress reactions such as tearfulness, anxiety, and insomnia.

Because a recent meta-analysis supports these observations,12 follow-up evaluation for signs of PTSD is recommended for:

  • survivors with one or more of the risk factors discussed above
  • vulnerable groups such as rescue workers, children, and dependent individuals
  • survivors whose symptoms persist after 2 months.13

Decompensation immediately after a disaster seems to be the exception for psychiatric patients, despite their longer-term vulnerability. One psychiatrist who in 1989 survived Hurricane Hugo—the most intense storm to strike the Mid-Atlantic region in 100 years—noted that demand for inpatient psychiatric services did not increase in the storm’s aftermath. The only patient calls she received were inquiries about her own physical safety.14

 

 

Caregivers and rescue workers—including psychi-atrists—are also disaster survivors, and you need to tend to your needs for safety and support. Consult frequently with colleagues within and outside the disaster area, as much for support as for information and guidance.15 Remember also that rescue workers are occasionally targets for victims’ rage at their circumstances. Anticipating and explaining this displacement reduces its toxicity.

Using medications

Uses psychotropics judiciously in the first 48 hours of trauma. Medication effects may interfere with neurologic assessment of the injured, and monitoring and follow-up may not be possible.

However, drug therapy should start quickly when survivors are acutely psychotic or their behavior endangers themselves, others, or the milieu. Medications usually include a fast-acting benzodiazepine and/or an antipsychotic, as described in guidelines for managing agitation.16 Always provide structure and supervision for medicated patients.

No guidelines exist for using medications to manage distressing—but less-severe—acute stress-related symptoms. Some experts advocate using adrenergic antagonists such as clonidine, guanfacine, and beta blockers to reduce excessive arousal. These drugs have not been adequately studied in this setting, however, and may harm those with cardiovascular instability from preexisting conditions or injuries.

Table 3

Psychoeducation: Simple messages for workers and trauma survivors

Get adequate rest, food, sleep
Avoid exposure to trauma cues, including TV images
Seek support from loved ones and peers
Talk about events and feelings only if this feels comfortable and helpful
Return to normal routine as much as possible
Take action to rebuild, but at a reasonable pace
Reach out to others who may need assistance
Get help:
  • immediately for abnormal reactions (psychosis, suicidality, risky behavior including substance abuse)
  • if normal reactions (insomnia, anxiety, mild dissociation) persist beyond 2 months
  • if at high risk for persistent reaction (bereaved, injured, prior trauma or psychiatric disorder, no social support)

Short-term (<1 week) benzodiazepine use for panic symptoms and severe insomnia is acceptable, but longer-term use may increase PTSD risk.17 A selective serotonin reuptake inhibitor may help individuals with pre-existing PTSD or depression, if you can arrange follow-up.

In the aftermath

‘Debriefing.’ Critical incident stress debriefing (CISD) is a structured, one-session group intervention in which survivors’ experiences and emotional reactions are discussed and education and follow-up recommendations are provided. Developed by Mitchell in 1983,18 CISD was widely used until systematic evaluations revealed that it did not alleviate psychological distress or prevent PTSD.19

Table 4

How to interact with news media during and after a disaster

For organizations
Identify a spokesperson with media experience beforehand
Ensure that the spokesperson is well-informed about all aspects of the disaster
For spokespersons
Always
  • Reply immediately to news media requests; find out the reporter’s deadline and refer the caller if you cannot meet it
  • Clearly identify yourself and the organization you represent
  • Understand what the reporter needs—what’s “behind the story”
  • Use simple, declarative sentences; avoid medical jargon
  • Emphasize one or two points
  • Be accurate and honest but use a positive, hopeful frame
  • On TV, look at the interviewer, not the camera
Never
  • Speak off the record
  • Discuss individual cases
  • Speculate on diagnosis or treatment for someone you have not examined (such as a terrorist leader)

Thus, although survivor meetings may provide information, education, screening, and support, avoid detailed discussions of events and emotions. Any meetings should be conducted by mental health clinicians and should not be mandatory. Reserve the term “debriefing” for operational reviews by rescue personnel.20

Public education. Educate survivors, rescue workers, health care providers, teachers, and relief agency workers. Provide concise, simple messages as suggested in Table 3. News media provide our most effective means of reaching out to survivors, which is why having a pre-existing relationship is so important. Some guidelines for working with the media are presented in Table 4.

Outreach. Numerous educational resources are available for survivors and their caregivers (see Related resources). Other potentially useful outreach tools include:

  • meetings with teachers’ organizations
  • continuing medical education activities for primary care providers
  • telephone hot lines.

Legal and ethical issues

Disaster scenes are chaotic and informal, and professionals must be flexible, often providing general support and information rather than specific clinical interventions. However, it is important in each encounter to decide whether a patient-physician relationship has begun.

As a general rule, a physician-patient relationship is established whenever diagnosis or treatment is discussed. Once that happens, briefly document:

  • signs and symptoms
  • working diagnosis
  • suicide or violence potential
  • treatment and/or follow-up plans.

Confidentiality may be difficult to preserve in chaotic situations involving workers from many agencies. Even in disasters, however, you must obtain permission before sharing information unless the individual’s situation is emergent.

Table 5

 

 

Keys to effective disaster psychiatry

Be prepared
  • Contact your local American Psychiatric Association district branch or American Red Cross chapter to learn about existing mental health disaster plans
  • Remember the three basics of psychic resiliency: safety, support, and efficacy
  • Know your place, ask for help, and use existing resources
Care for survivors
  • Your presence alone may be healing
  • Assess thoroughly; symptoms may be related to medical issues or pre-existing conditions, not just stress response
  • Do no harm; avoid psychological debriefing interventions and unnecessary medications
  • Follow up with survivors who exhibit risk factors or symptoms persisting >2 months
  • Consider trauma-focused CBT for survivors with acute stress disorder
Care for yourself
  • As a survivor, tend to your own safety and self-care needs
  • Consult frequently with colleagues within and outside the disaster area for support, information, and guidance

Long-term interventions

Longer-term disaster interventions include continued outreach and education and needed follow-up services. Existing structures may provide effective follow-up, but additional resources are often needed.

Federal programs. Following a presidentialdeclared disaster, the Federal Emergency Management Agency (FEMA) provides funding for crisis counseling. Programs are typically funded for 9 to 15 months and administered through the emergency services and disaster relief branch of the Substance Abuse and Mental Health Services Administration (SAMHSA) and community mental health organizations. Examples include Project Heartland following the 1995 Oklahoma City federal building bombing and Project COPE following California’s 1989 Loma Prieta earthquake.

Cognitive-behavioral therapy. For adult survivors with acute stress disorder, specific cognitive-behavioral therapy (CBT) provided by trained therapists may prevent PTSD and other trauma sequelae, such as depression.21 CBT interventions may begin as early as 2 weeks after trauma and focus sequentially on anxiety management, cognitive restructuring, imaginal exposure followed by in vivo exposure, and relapse prevention.

Three controlled trials found 6-month PTSD rates of 14% to 20% among acute stress disorder patients treated with CBT, compared with 58% to 67% with supportive counseling.22-24 Although studies of interventions immediately following trauma are lacking, trauma-focused CBT is also recommended for children.25 Evidence-based treatments for PTSD are discussed in detail elsewhere.26

Not unprepared after all

With some reflection, Dr. Z realized she had the tools to help her community. Her feelings of helplessness receded as she envisioned how she could help survivors understand their experiences, re-create a sense of safety, restore important connections to loved ones, and begin to rebuild their lives (Table 5).

Related resources

For clinicians

  • Young BH, Ford JD, Ruzek JI, et al. Disaster mental health: a guidebook for clinicians and administrators. Washington, DC: National Center for Post-Traumatic Stress Disorder, 1998. http://ncptsd.org/publications/disaster/index.html
  • Hillman JL. Crisis intervention and trauma: new approaches to evidence-based practice. New York: Kluwer Academic/Plenum Publishers, 2002.
  • Office of the Surgeon General Web site on medical aspects of nuclear, biological, and chemical warfare. http://www.nbc-med.org

For survivors and clinicians

Drug brand names

  • Clonidine • Catapres
  • Guanfacine • Tenex

Disclosure

The authors report no financial relationship with any company whose products are mentioned in this article or with manufacturers of competing products.

The night started like any other for Dr. Z. Kids in bed (too late) by 10:30, dog out by 11, fell asleep reading journal by 11:15. Sirens jolt her out of a solid stage 4. Her eyes widen, pulse quickens, mouth dries as she follows the glow of the TV into the living room. On TV, fire frames shots of tearful faces, body bags, and firefighters in protective suits. She catches the announcer’s voice: “…explosion at City Power and Light nuclear facility at 3:10 AM today. Fifty-five are known dead, and thousands are being told to evacuate. The blast’s cause is unknown, but terrorism is suspected.”

As her numbness slowly ebbs, Dr. Z’s questions rise insistently. How can I help the survivors? My patients? My children? What if the media call me? How could I have been better prepared for this?

Disaster shakes us to our human and biological core. More than any other clinical encounter, it reminds us that psychiatrists share the vulnerabilities of those we seek to help. Yet it also reminds us that even simple concepts and interventions can mobilize the healing process.

Are you ready to provide emergency psychiatric care following a disaster in your community—be it a nuclear accident, tornado, airplane crash, or terrorist act? Here is evidence—some counterintuitive—that can help you prepare.

Table 1

‘Psychological first aid’ for disaster survivors

Re-create sense of safety
  • Provide for basic needs (food, clothing, medical care)
  • Ensure that survivors are safe and protected from reminders of the event
  • Protect them from onlookers and the media
  • Help them establish a “personal space” and preserve privacy and modesty
Encourage social support
  • Help survivors connect with family and friends (most urgently, children with parents)
  • Educate family and friends about survivors’ normal reactions and how they can help
Re-establish sense of efficacy
  • Give survivors accurate, simple information about plans and events
  • Allow survivors to discuss events and feelings, but do not probe
  • Encourage them to re-establish normal routines and roles when possible
  • Help resolve practical problems, such as getting transportation or relief vouchers
  • Discuss self-care and strategies to reduce anxiety, such as grounding and relaxation techniques
  • Encourage survivors to support and assist others

Disaster’s psychobiology

Human reactions to disaster are often conceptualized as the mammalian survival response: flight, fight, and fright (freezing). In most cases, these reactions are adaptive and dissipate after safety is restored. Posttraumatic stress disorder (PTSD) develops in about 5% of natural disaster victims and 33% of mass shooting victims.1

Responses that do go awry appear to be associated with abnormally low cortisol and persistent adrenergic activation, leading to sensitization of the fear response.2 Reminders of trauma or persistent stressors—such as pain, problems with finances or housing, or bereavement—may exacerbate sensitization. On the other hand, preclinical studies suggest that social support3,4 and active coping5 mitigate physiologic stress responses, confirming numerous clinical observations that associate lack of social support and avoidant coping with eventual PTSD development.

Three basics. Just as our emergency medicine colleagues must often revert to life-support basics, we must remind ourselves of biology’s three basics for psychic resilience:

  • safety (including—as much as possible—protection from reminders of trauma and ongoing stress)
  • meaningful social connection
  • re-establishing a sense of efficacy to overcome helplessness (Table 1).

Like the stress response, these protective factors seem hard-wired into our biological make-up. They form the foundation for all phases of disaster psychiatry interventions, from planning to immediate interventions through longterm follow-up.

Disaster planning

As a mental health professional, plan to operate within established disaster plans and agencies, not only for the sake of efficiency but also because structure and support are paramount in disaster situations. Check with the American Psychiatric Association’s local branch to determine if a disaster mental health plan exists. If not, explore how to work directly with local American Red Cross chapters and hospitals, which recruit personnel for the Disaster Medical Assistance Teams mobilized by the public health service.

Table 2

Normal reactions to disaster for adults and children

All ages
EmotionalShock, fear, grief, anger, guilt, shame, helplessness, hopelessness, numbness, emptiness Decreased ability to feel interest, pleasure, love
CognitiveConfusion, disorientation, indecisiveness, worry, shortened attention span, poor concentration, memory difficulties, unwanted memories, self-blame
PhysicalTension, fatigue, edginess, insomnia, generalized aches and pains, startling easily, rapid heartbeat, nausea, decreased appetite and sex drive
InterpersonalDifficulties being intimate, being over-controlling, feeling rejected or abandoned
Children’s age-specific disaster responses
PreschoolSeparation fears, regression, fussiness, temper tantrums, somatization Sleep disturbances including nightmares, somnambulism, night terrors
School-ageMay still have the above, as well as excessive guilt and worries about others’ safety, poor concentration and loss of school performance, repetitious re-telling or play related to trauma
AdolescentDepression, acting out, wish for revenge, sleeping and eating disturbances, altered view of the future
 

 

Immediate disaster mental health plans vary in detail according to local needs and resources but should at least address:

  • providing on-site interventions
  • disseminating information about responses to trauma
  • identifying and publicizing local mental health resources.

Immediate interventions

Immediately following a disaster, psychiatrists are frequently asked to assist with on-site crisis and medical interventions, evaluate survivors with unusual or intense reactions, and provide public education about psychological reactions to disaster.

On-site response. All responders, regardless of discipline, should provide disaster survivors with “psychological first aid,” which is directed at reestablishing safety, connection, and efficacy. Basic crisis intervention principles are useful when support and reassurance are not enough.6

For example, relaxation exercises can reduce anxiety and improve sleep. Use focused, structured relaxation tools—such as progressive muscle relaxation and breathing training—as unstructured exercises can exacerbate dissociation and re-experiencing. Grounding techniques, by which survivors learn to focus all senses on immediate surroundings, often alleviate dissociation and flashbacks.

Care for children. Because children’s reactions to disaster greatly depend on their caregivers’ responses (social referencing), focus acute interventions for children on:

  • re-connecting them with their families
  • reducing caregivers’ distress
  • educating caregivers about providing age appropriate information and support (see Related resources).

Medical care. As physicians, psychiatrists may be called upon to intervene medically. Although it is generally advisable to stay within our usual practice, medical personnel may be in short supply. Fortunately, Good Samaritan laws exist in every state, and the potential for a successful malpractice suit against a physician responding in a disaster is almost zero, unless the physician’s performance is grossly negligent (such as moving the neck of a patient with obvious head or neck injuries).7

Principles regarding informed consent and right to refuse treatment—along with the usual exceptions—apply during disasters.

Evaluating survivors in shelters and hospitals requires knowing the normal and abnormal responses to disaster, being able to differentially diagnose changes in mental status, and understanding risk factors for trauma’s psychiatric sequelae. Aside from PTSD, trauma’s long-term effects include other anxiety disorders, depression, substance abuse, and eating disorders. In addition to the usual components of a psychiatric evaluation, assessments must address event-related factors such as proximity to the disaster, loss of significant others or property, physical injuries, immediate needs, and social support.8

Normal stress reactions. Frequently described as “a normal response to an abnormal situation,” the normal stress reaction is multidimensional and depends on the person’s developmental level (Table 2). About 10% to 25% of survivors experience intense affect and dissociation, whereas a similar number may appear unusually calm.

Interventions beyond the“first aid” described above are not usually needed unless individuals:

  • are a danger to themselves or others
  • are psychotic
  • have no social supports
  • cannot perform tasks necessary for self-care and to begin the recovery process.

Always re-assess when there is any question about a survivor’s immediate reaction to trauma.

In DSM-IV-TR’s trauma-related diagnoses, the symptom clusters often do not capture many disaster survivors’ subjective experience: the shattering of fundamental beliefs regarding themselves (invulnerability), the world (predictability, safety), and others (trust, benevolence).9 By empathizing with these responses, you can help survivors feel less isolated and estranged.

Differential diagnosis. Survivors’ mental status changes may be manifestations of the stress response, but they also may represent:

  • exacerbations of pre-existing psychiatric or general medical conditions
  • hypoxemia, hypovolemia, or CNS trauma from physical injury
  • responses to medications used for resuscitation or pain control, such as atropine, epinephrine, lidocaine, or morphine.

Effects of bioterrorism agents must also be considered. For example, organophosphorus compounds such as the nerve agents sarin and soman can cause impaired concentration, depression, and anxiety. Anthrax can cause rapidly progressing meningitis.10 Delirium must be differentiated from dissociation; patients with dissociation can be re-oriented, and changes will resolve with time rather than fluctuate.11

Psychopathology risk factors. Multiple studies have addressed risk factors for post-disaster psychiatric sequelae (usually PTSD). In general, risk increases with repeated trauma exposure (including TV viewing), prior trauma, lack of social support, injury, pre-existing psychiatric problems, traumatic bereavement (having witnessed the violent death of a loved one), avoidant coping, and having strong negative beliefs about the meanings of normal stress reactions such as tearfulness, anxiety, and insomnia.

Because a recent meta-analysis supports these observations,12 follow-up evaluation for signs of PTSD is recommended for:

  • survivors with one or more of the risk factors discussed above
  • vulnerable groups such as rescue workers, children, and dependent individuals
  • survivors whose symptoms persist after 2 months.13

Decompensation immediately after a disaster seems to be the exception for psychiatric patients, despite their longer-term vulnerability. One psychiatrist who in 1989 survived Hurricane Hugo—the most intense storm to strike the Mid-Atlantic region in 100 years—noted that demand for inpatient psychiatric services did not increase in the storm’s aftermath. The only patient calls she received were inquiries about her own physical safety.14

 

 

Caregivers and rescue workers—including psychi-atrists—are also disaster survivors, and you need to tend to your needs for safety and support. Consult frequently with colleagues within and outside the disaster area, as much for support as for information and guidance.15 Remember also that rescue workers are occasionally targets for victims’ rage at their circumstances. Anticipating and explaining this displacement reduces its toxicity.

Using medications

Uses psychotropics judiciously in the first 48 hours of trauma. Medication effects may interfere with neurologic assessment of the injured, and monitoring and follow-up may not be possible.

However, drug therapy should start quickly when survivors are acutely psychotic or their behavior endangers themselves, others, or the milieu. Medications usually include a fast-acting benzodiazepine and/or an antipsychotic, as described in guidelines for managing agitation.16 Always provide structure and supervision for medicated patients.

No guidelines exist for using medications to manage distressing—but less-severe—acute stress-related symptoms. Some experts advocate using adrenergic antagonists such as clonidine, guanfacine, and beta blockers to reduce excessive arousal. These drugs have not been adequately studied in this setting, however, and may harm those with cardiovascular instability from preexisting conditions or injuries.

Table 3

Psychoeducation: Simple messages for workers and trauma survivors

Get adequate rest, food, sleep
Avoid exposure to trauma cues, including TV images
Seek support from loved ones and peers
Talk about events and feelings only if this feels comfortable and helpful
Return to normal routine as much as possible
Take action to rebuild, but at a reasonable pace
Reach out to others who may need assistance
Get help:
  • immediately for abnormal reactions (psychosis, suicidality, risky behavior including substance abuse)
  • if normal reactions (insomnia, anxiety, mild dissociation) persist beyond 2 months
  • if at high risk for persistent reaction (bereaved, injured, prior trauma or psychiatric disorder, no social support)

Short-term (<1 week) benzodiazepine use for panic symptoms and severe insomnia is acceptable, but longer-term use may increase PTSD risk.17 A selective serotonin reuptake inhibitor may help individuals with pre-existing PTSD or depression, if you can arrange follow-up.

In the aftermath

‘Debriefing.’ Critical incident stress debriefing (CISD) is a structured, one-session group intervention in which survivors’ experiences and emotional reactions are discussed and education and follow-up recommendations are provided. Developed by Mitchell in 1983,18 CISD was widely used until systematic evaluations revealed that it did not alleviate psychological distress or prevent PTSD.19

Table 4

How to interact with news media during and after a disaster

For organizations
Identify a spokesperson with media experience beforehand
Ensure that the spokesperson is well-informed about all aspects of the disaster
For spokespersons
Always
  • Reply immediately to news media requests; find out the reporter’s deadline and refer the caller if you cannot meet it
  • Clearly identify yourself and the organization you represent
  • Understand what the reporter needs—what’s “behind the story”
  • Use simple, declarative sentences; avoid medical jargon
  • Emphasize one or two points
  • Be accurate and honest but use a positive, hopeful frame
  • On TV, look at the interviewer, not the camera
Never
  • Speak off the record
  • Discuss individual cases
  • Speculate on diagnosis or treatment for someone you have not examined (such as a terrorist leader)

Thus, although survivor meetings may provide information, education, screening, and support, avoid detailed discussions of events and emotions. Any meetings should be conducted by mental health clinicians and should not be mandatory. Reserve the term “debriefing” for operational reviews by rescue personnel.20

Public education. Educate survivors, rescue workers, health care providers, teachers, and relief agency workers. Provide concise, simple messages as suggested in Table 3. News media provide our most effective means of reaching out to survivors, which is why having a pre-existing relationship is so important. Some guidelines for working with the media are presented in Table 4.

Outreach. Numerous educational resources are available for survivors and their caregivers (see Related resources). Other potentially useful outreach tools include:

  • meetings with teachers’ organizations
  • continuing medical education activities for primary care providers
  • telephone hot lines.

Legal and ethical issues

Disaster scenes are chaotic and informal, and professionals must be flexible, often providing general support and information rather than specific clinical interventions. However, it is important in each encounter to decide whether a patient-physician relationship has begun.

As a general rule, a physician-patient relationship is established whenever diagnosis or treatment is discussed. Once that happens, briefly document:

  • signs and symptoms
  • working diagnosis
  • suicide or violence potential
  • treatment and/or follow-up plans.

Confidentiality may be difficult to preserve in chaotic situations involving workers from many agencies. Even in disasters, however, you must obtain permission before sharing information unless the individual’s situation is emergent.

Table 5

 

 

Keys to effective disaster psychiatry

Be prepared
  • Contact your local American Psychiatric Association district branch or American Red Cross chapter to learn about existing mental health disaster plans
  • Remember the three basics of psychic resiliency: safety, support, and efficacy
  • Know your place, ask for help, and use existing resources
Care for survivors
  • Your presence alone may be healing
  • Assess thoroughly; symptoms may be related to medical issues or pre-existing conditions, not just stress response
  • Do no harm; avoid psychological debriefing interventions and unnecessary medications
  • Follow up with survivors who exhibit risk factors or symptoms persisting >2 months
  • Consider trauma-focused CBT for survivors with acute stress disorder
Care for yourself
  • As a survivor, tend to your own safety and self-care needs
  • Consult frequently with colleagues within and outside the disaster area for support, information, and guidance

Long-term interventions

Longer-term disaster interventions include continued outreach and education and needed follow-up services. Existing structures may provide effective follow-up, but additional resources are often needed.

Federal programs. Following a presidentialdeclared disaster, the Federal Emergency Management Agency (FEMA) provides funding for crisis counseling. Programs are typically funded for 9 to 15 months and administered through the emergency services and disaster relief branch of the Substance Abuse and Mental Health Services Administration (SAMHSA) and community mental health organizations. Examples include Project Heartland following the 1995 Oklahoma City federal building bombing and Project COPE following California’s 1989 Loma Prieta earthquake.

Cognitive-behavioral therapy. For adult survivors with acute stress disorder, specific cognitive-behavioral therapy (CBT) provided by trained therapists may prevent PTSD and other trauma sequelae, such as depression.21 CBT interventions may begin as early as 2 weeks after trauma and focus sequentially on anxiety management, cognitive restructuring, imaginal exposure followed by in vivo exposure, and relapse prevention.

Three controlled trials found 6-month PTSD rates of 14% to 20% among acute stress disorder patients treated with CBT, compared with 58% to 67% with supportive counseling.22-24 Although studies of interventions immediately following trauma are lacking, trauma-focused CBT is also recommended for children.25 Evidence-based treatments for PTSD are discussed in detail elsewhere.26

Not unprepared after all

With some reflection, Dr. Z realized she had the tools to help her community. Her feelings of helplessness receded as she envisioned how she could help survivors understand their experiences, re-create a sense of safety, restore important connections to loved ones, and begin to rebuild their lives (Table 5).

Related resources

For clinicians

  • Young BH, Ford JD, Ruzek JI, et al. Disaster mental health: a guidebook for clinicians and administrators. Washington, DC: National Center for Post-Traumatic Stress Disorder, 1998. http://ncptsd.org/publications/disaster/index.html
  • Hillman JL. Crisis intervention and trauma: new approaches to evidence-based practice. New York: Kluwer Academic/Plenum Publishers, 2002.
  • Office of the Surgeon General Web site on medical aspects of nuclear, biological, and chemical warfare. http://www.nbc-med.org

For survivors and clinicians

Drug brand names

  • Clonidine • Catapres
  • Guanfacine • Tenex

Disclosure

The authors report no financial relationship with any company whose products are mentioned in this article or with manufacturers of competing products.

References

1. Effects of traumatic stress in a disaster situation. Washington, DC: National Center for Post-Traumatic Stress Disorder. Department of Veterans Affairs, September 12, 2001 (Accessed March 31, 2004 at http://www.ncptsd.org/facts/disasters/fs_effects_disaster.html).

2. Yehuda R, McFarlane AC, Shalev AY. Predicting the development of post-traumatic stress disorder from the acute response to a traumatic event. Biol Psychiatry 1998;44:1305-13.

3. Levine S, Lyons DM, Schatzberg AF. Psychobiological consequences of social relationships. Ann NY Acad Sci 1997;807:210-18.

4. Uchino BN, Garvey TS. The availability of social support reduces cardiovascular reactivity to acute psychological stress. J Behav Med 1997;20:15-27.

5. LeDoux JE, Gorman JM. A call to action: overcoming anxiety through active coping. Am J Psychiatry 2001;158:1953-5.

6. Hillman JL. Crisis intervention and trauma: new approaches to evidence-based practice. New York: Kluwer Academic/Plenum Publishers, 2002.

7. Daniels G. Good Samaritan acts. Emerg Med Clin North Am 1999;17:491-504.

8. Mental-health intervention for disasters. Washington, DC: National Center for Post-Traumatic Stress Disorder, Department of Veterans Affairs, Sept. 12, 2001. (Accessed March 31, 2004 at http://www.ncptsd.org/facts/disasters/fs_treatment_disaster.html.)

9. Difede J, Apfeldorf WJ, Cloitre M, et al. Acute psychiatric responses to the explosion at the World Trade Center: a case series. J Nerv Ment Dis 1997;185:519-22.

10. DiGiovanni C. Domestic terrorism with chemical or biological agents: psychiatric aspects. Am J Psychiatry 1999;156:1500-5.

11. Rundle JR. Psychiatric issues in medical-surgical disaster casualties: consultation-liaison approach. Psychiatr Q 2000;71:245-58.

12. Brewin CR, Andrews B, Valentine JD. Meta-analysis of risk factors for post-traumatic stress disorder in trauma-exposed adults. J Consult Clin Psychol 2000;68:748-66.

13. Mental health and mass violence: evidence-based early psychological intervention for victims/survivors of mass violence. Washington, DC: National Institute of Mental Health, Nov. 1, 2002 (Accessed Oct. 29, 2003 at http://www.nimh.nih.gov/research/massviolence.pdf.)

14. Austin LS. Organizing a disaster response program in one’s home community. In: Austin LS (ed). Responding to disaster: a guide for mental health professionals. Washington, DC: American Psychiatric Publishing, 1992;53-68.

15. Rousseau AW. Notes from Oklahoma City’s recovery. In: Hall RCW, Norwood AE (eds). Disaster psychiatry handbook. Washington, DC: American Psychiatric Association Committee on Psychiatric Dimensions of Disaster, undated:3-11. (Accessed Oct. 29, 2003 at http://www.psych.org/disasterpsych/pdfs/apadisasterhandbk.pdf.)

16. Yildiz A, Sachs GS, Turgay A. Pharmacological management of agitation in emergency settings. Emerg Med J 2003;20:339-46.

17. Gelpin E, Bonne O, Peri T, et al. Treatment of recent trauma survivors with benzodiazepines: a prospective study. J Clin Psychiatry 1996;57:390-4.

18. Mitchell JT. When disaster strikes. J Em Med Serv 1983;8:36-9.

19. Rose S, Bisson J, Wessely S. Psychological debriefing for preventing posttraumatic stress disorder (PTSD). Cochrane Database Syst Rev 2002;(2):CD000560.-

20. Black J. Forming the libidinal cocoon: the Dallas airplane crashes, the Guadalupe river drownings, and Hurricane Hugo in the Virgin Islands. In: Austin LS (ed). Responding to disaster: a guide for mental health professionals. Washington DC: American Psychiatric Publishing, 1992;169:84.-

21. Ehlers A, Clark DM. Early psychological interventions for adult survivors of trauma: a review. Biol Psychiatry 2003;53:817-26.

22. Bryant RA, Moulds M, Guthrie R, Nixon RD. Treating acute stress disorder following mild traumatic brain injury. Am J Psychiatry 2003;160:585-7.

23. Bryant RA, Sackville T, Dang ST, et al. Treating acute stress disorder: an evaluation of cognitive behavior therapy and supportive counseling techniques. Am J Psychiatry 1999;156:1780-6.

24. Bryant RA, Harvey AG, Dang ST, et al. Treatment of acute stress disorder: a comparison of cognitive-behavioral therapy and supportive counseling. J Consult Clin Psychol 1998;66:862-6.

25. Cohen JA. Treating acute posttraumatic reactions in children and adolescents. Biol Psychiatry 2003;53:827-33.

26. Foa EB, Keane TM, Friedman MJ. Effective treatments for PTSD. New York: Guilford Press, 2000.

References

1. Effects of traumatic stress in a disaster situation. Washington, DC: National Center for Post-Traumatic Stress Disorder. Department of Veterans Affairs, September 12, 2001 (Accessed March 31, 2004 at http://www.ncptsd.org/facts/disasters/fs_effects_disaster.html).

2. Yehuda R, McFarlane AC, Shalev AY. Predicting the development of post-traumatic stress disorder from the acute response to a traumatic event. Biol Psychiatry 1998;44:1305-13.

3. Levine S, Lyons DM, Schatzberg AF. Psychobiological consequences of social relationships. Ann NY Acad Sci 1997;807:210-18.

4. Uchino BN, Garvey TS. The availability of social support reduces cardiovascular reactivity to acute psychological stress. J Behav Med 1997;20:15-27.

5. LeDoux JE, Gorman JM. A call to action: overcoming anxiety through active coping. Am J Psychiatry 2001;158:1953-5.

6. Hillman JL. Crisis intervention and trauma: new approaches to evidence-based practice. New York: Kluwer Academic/Plenum Publishers, 2002.

7. Daniels G. Good Samaritan acts. Emerg Med Clin North Am 1999;17:491-504.

8. Mental-health intervention for disasters. Washington, DC: National Center for Post-Traumatic Stress Disorder, Department of Veterans Affairs, Sept. 12, 2001. (Accessed March 31, 2004 at http://www.ncptsd.org/facts/disasters/fs_treatment_disaster.html.)

9. Difede J, Apfeldorf WJ, Cloitre M, et al. Acute psychiatric responses to the explosion at the World Trade Center: a case series. J Nerv Ment Dis 1997;185:519-22.

10. DiGiovanni C. Domestic terrorism with chemical or biological agents: psychiatric aspects. Am J Psychiatry 1999;156:1500-5.

11. Rundle JR. Psychiatric issues in medical-surgical disaster casualties: consultation-liaison approach. Psychiatr Q 2000;71:245-58.

12. Brewin CR, Andrews B, Valentine JD. Meta-analysis of risk factors for post-traumatic stress disorder in trauma-exposed adults. J Consult Clin Psychol 2000;68:748-66.

13. Mental health and mass violence: evidence-based early psychological intervention for victims/survivors of mass violence. Washington, DC: National Institute of Mental Health, Nov. 1, 2002 (Accessed Oct. 29, 2003 at http://www.nimh.nih.gov/research/massviolence.pdf.)

14. Austin LS. Organizing a disaster response program in one’s home community. In: Austin LS (ed). Responding to disaster: a guide for mental health professionals. Washington, DC: American Psychiatric Publishing, 1992;53-68.

15. Rousseau AW. Notes from Oklahoma City’s recovery. In: Hall RCW, Norwood AE (eds). Disaster psychiatry handbook. Washington, DC: American Psychiatric Association Committee on Psychiatric Dimensions of Disaster, undated:3-11. (Accessed Oct. 29, 2003 at http://www.psych.org/disasterpsych/pdfs/apadisasterhandbk.pdf.)

16. Yildiz A, Sachs GS, Turgay A. Pharmacological management of agitation in emergency settings. Emerg Med J 2003;20:339-46.

17. Gelpin E, Bonne O, Peri T, et al. Treatment of recent trauma survivors with benzodiazepines: a prospective study. J Clin Psychiatry 1996;57:390-4.

18. Mitchell JT. When disaster strikes. J Em Med Serv 1983;8:36-9.

19. Rose S, Bisson J, Wessely S. Psychological debriefing for preventing posttraumatic stress disorder (PTSD). Cochrane Database Syst Rev 2002;(2):CD000560.-

20. Black J. Forming the libidinal cocoon: the Dallas airplane crashes, the Guadalupe river drownings, and Hurricane Hugo in the Virgin Islands. In: Austin LS (ed). Responding to disaster: a guide for mental health professionals. Washington DC: American Psychiatric Publishing, 1992;169:84.-

21. Ehlers A, Clark DM. Early psychological interventions for adult survivors of trauma: a review. Biol Psychiatry 2003;53:817-26.

22. Bryant RA, Moulds M, Guthrie R, Nixon RD. Treating acute stress disorder following mild traumatic brain injury. Am J Psychiatry 2003;160:585-7.

23. Bryant RA, Sackville T, Dang ST, et al. Treating acute stress disorder: an evaluation of cognitive behavior therapy and supportive counseling techniques. Am J Psychiatry 1999;156:1780-6.

24. Bryant RA, Harvey AG, Dang ST, et al. Treatment of acute stress disorder: a comparison of cognitive-behavioral therapy and supportive counseling. J Consult Clin Psychol 1998;66:862-6.

25. Cohen JA. Treating acute posttraumatic reactions in children and adolescents. Biol Psychiatry 2003;53:827-33.

26. Foa EB, Keane TM, Friedman MJ. Effective treatments for PTSD. New York: Guilford Press, 2000.

Issue
Current Psychiatry - 03(05)
Issue
Current Psychiatry - 03(05)
Page Number
12-23
Page Number
12-23
Publications
Publications
Topics
Article Type
Display Headline
Psychological first aid: Emergency care for terrorism and disaster survivors
Display Headline
Psychological first aid: Emergency care for terrorism and disaster survivors
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Trichotillomania: A heads-up on severe cases

Article Type
Changed
Tue, 12/11/2018 - 15:31
Display Headline
Trichotillomania: A heads-up on severe cases

History: Bald at age 9

Ms. D, age 41, began compulsively pulling out and eating her hair at age 8. When she didn’t get her way at home or was nervous about school, she would sit for hours, pulling and eating a strand or two at a time, ultimately ingesting a clump of hair.

By age 9, Ms. D was bald. In grade school, she often wore hats and scarves to class to avoid teasing from other children about her baldness. In high school, she kept to herself and frequently wore wigs.

Ms. D stops pulling for brief periods and her hair grows out, but she invariably resumes pulling when psychosocial stressors mount. Many of life’s normal anxieties—job interviews, work-related stress, social rejection—trigger episodes.

When she is bald, Ms. D pulls and eats hair off her wig. Over the years, she has spent thousands of dollars on custom-made wigs that mask her baldness while feeding her habit.

Ms. D’s episodes are increasingly interfering with her life. She has been steadily employed as an office assistant, but does not socialize with coworkers. She has not dated in years, and during an exacerbation leaves home only to go to work. She also pulls her eyelashes and eyebrows and picks her nails and cuticles.

Ms. D first presented in 1994 after seeing a television segment I did on trichotillomania. At intake, she was wearing a wig and exhibited anxious mood. She also has Crohn’s disease; a gastroenterologist monitors her closely.

Ms. D reports compulsive counting and checking but denies other similar behaviors. No immediate family members have exhibited obsessive-compulsive or hair-pulling behaviors. Her father abused alcohol and a sister has a stuttering problem, although Ms. D denies that these have affected her psychologically.

Ms. D’s hair-pulling behavior suggests:

  • a pica disorder
  • an impulse control disorder
  • or an obsessive-compulsive disorder?

Box

DSM-IV-TR diagnostic criteria for trichotillomania

  1. Recurrent pulling out of one’s own hair, resulting in noticeable hair loss.
  2. Increasing tension immediately before pulling out the hair or when attempting to resist the behavior.
  3. Pleasure, gratification, or relief while pulling out the hair.
  4. The disturbance is not better explained as another mental disorder and is not caused by a dermatological or other general medical condition.
  5. The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.

Source: Reprinted with permission from the Diagnostic and statistical manual of mental disorders, 4th ed., text revision. Copyright 2000. American Psychiatric Association.

Dr. Lundt’s observations

Trichotillomania, defined as compulsive pulling of hair, usually begins in childhood or adolescence. Scalp hair is most commonly pulled, but some patients also pull their eyelashes, pubic hair, and other body hair. Some, especially children, have reportedly pulled their pets’ hair.

Mansueto et al estimate that trichotillomania afflicts approximately 1.5% of males and 3.5% of females.1 These estimates, however, do not include persons with the disorder who are too embarrassed to seek treatment.

DSM-IV-TR classifies trichotillomania as an impulse control disorder (Box). Although comorbid anxiety and depressive disorders are common, Ms. D did not meet criteria for any other psychiatric disorder.

Trichotillomania often is episodic. Months or years of abstinence is common after periods of exacerbation, usually caused by stress (Figure).

Many clinicians mistakenly consider trichotillomania a benign disorder with few consequences beyond alopecia.2 Some patients, however, progress into trichophagia—ingestion of pulled hair. Trichophagia is a form of pica disorder, typically defined as persistent eating of non-nutritive substances. Patients often harbor tremendous shame over their hair-eating behavior and resist psychiatric or medical treatment.2

The undigested hair can form sometimes massive clumps called trichobezoars, which are most common among children and the developmentally disabled.4 Persons with trichophagia face a 37.5% risk of forming a trichobezoar.5 The mass can cause abdominal pain, nausea, vomiting, and weight loss; complications include GI obstruction, ulceration, perforation, and peritonitis.6 An untreated trichobezoar can be fatal,7 although such deaths are rare among patients being treated for trichotillomania.

Patients with trichotillomania often respond to medications used to treat obsessive-compulsive disorder, such as clomipramine. Some clinicians believe this agent is more effective than selective serotonin reuptake inhibitors (SSRIs) but more difficult to tolerate. For Ms. D, I started with both.

Treatment: ‘I Don’t need medication’

Initial treatments—including fluoxetine, 20 mg/d for 6 months; hypnotherapy; and clomipramine, 25 mg/d—were unsuccessful. Ms. D was only marginally compliant, believing that she did not need medication.

I referred Ms. D to an out-of-state residential behavioral program specializing in trichotillomania, but she refused to go even as her hair-pulling intensified. Clomipramine was gradually increased to 75 mg nightly, briefly decreasing her pulling, then to 100 mg nightly when symptoms re-emerged. Clomipramine blood levels were monitored with each dosage change to guard against CNS and cardiac toxicity and other side effects (GI complaints, dizziness, cardiac arrhythmias, somnolence).

 

 

After watching for seasonal patterns, I found that Ms. D’s hair-pulling worsened during the winter, although no seasonal change in mood was detected. Phototherapy produced initial success, but Ms. D continued to pull her eyelashes.

Eight weeks later, however, Ms. D’s symptoms escalated. Clomipramine was increased to 150 mg nightly, resulting in blood levels of 99 ng/mL for clomipramine and 204 ng/mL for the metabolite N-desmethylclomipramine—both within the therapeutic range. As she continued pulling, I added buspirone, 10 mg/d.

At this point, would you:

  • continue clomipramine and increase the dosage?
  • discontinue clomipramine and start another psychotropic?
  • or maintain clomipramine at the same dosage and add another psychotropic?

Dr. Lundt’s observations

Drug treatment of trichotillomania has not been studied extensively or long-term, and no consensus exists. Psychoanalysis, cognitive-behavioral therapy (CBT), and hypnotherapy are usually administered with psychotropics.8 Patients often respond to treatment at first, then reach a plateau and resume pulling their hair.9

Numerous psychotropics are used off-label to treat trichotillomania. Several agents have been shown in clinical trials and case reports to reduce hair pulling/eating behaviors (Table), but these findings are limited by small sample size, lack of control groups, and lack of a standard symptom rating scale.

Figure Trichotillomania: Excessive grooming, habit, or vicious circle?



Most clinicians begin with SSRIs because they are generally well tolerated, even at high dosages. Monotherapy often is not adequate for trichotillomania, however. Medication augmentation is common, although little empiric data support this practice.

When clomipramine did not work initally, I explored serotonergic combination strategies.

Table

Medications shown to benefit patients with trichotillomania

DrugEvidenceDosage range (mg/d)Potential side effects
First-line
Tricyclic
 ClomipramineSwedo et al10 50 to 300Sedation, weight gain, cardiac arrythmias
SSRIs
 Fluoxetinevan Minnen et al11 20 to 60GI symptoms, insomnia
 FluvoxamineGabriel12 50 to 250Sexual dysfunction, weight gain
 ParoxetineRavindran et al13 20 to 60Sexual dysfunction, weight gain
 SertralineBradford and Gratzer14 50 to 200Sexual dysfunction, GI symptoms, insomnia
Second-line
Antipsychotics
 HaloperidolVan Ameringen et al15 0.25 to 2Sedation, EPS
 OlanzapineGupta and Gupta16 2.5 to 10Sedation, weight gain
 PimozideStein and Hollander17 25 to 200Restlessness, EPS
 QuetiapineKhouzam et al8 25 to 200Sedation
 RisperidoneGabriel12 Senturk and Tanriverdi18 0.5 to 4.0Sedation, hyperprolactinemia
Mood stabilizer
 LithiumChristenson et al19 900 to 1,500Increased thirst, weight gain, tremor
EPS: extrapyramidal symptoms

Further treatment: Relapse, resection

Ms. D was lost to follow-up for 1 year. She returned in 1996, just after undergoing a laparotomy for removal of a trichobezoar large enough to fill two 2-inch-by-6-inch bags. She also had been treated for pneumonia and a pulmonary embolus.

Riddled with shame and embarrassment, Ms. D had stopped pulling for 10 months, during which time she was off medication. Her pulling behaviors re-emerged, however, and clomipramine was restarted and titrated to 250 mg nightly.

One year later, a second trichobezoar was resected. Her clomipramine/N-desmethylclomipramine level reached 1,535 ng/mL, although an ECG reading was normal. Subsequent clomipramine/N-desmethylclomipramine blood levels were within the therapeutic range. Fluvoxamine, 25 mg/d titrated across 6 weeks to 150 mg/d, was added.

Again, Ms. D stopped taking her medications and was lost to follow-up. Her gastroenterologist began managing her care and started sertraline, dosage unknown, to address her depressed mood. A third trichobezoar was removed.

When Ms. D returned to my practice, I resumed CBT and increased sertraline over 1 month from 100 to 300 mg/d. Adding olanzapine, 2.5 mg/d, diminished her anxiety and markedly decreased her hair pulling.

Months later, her hair-pulling/eating behaviors again intensified, resulting in a small-bowel obstruction and a fourth trichobezoar removal. Olanzapine was increased to 5 mg nightly without significant benefit and with sedating effects.

Clomipramine, 125 mg/d, was reintroduced and her symptoms improved dramatically. On a regimen of sertraline, clomipramine and olanzapine, Ms. D remained stable for 2 years.

Last year, however, a fifth trichobezoar measuring 20 x 15 cm was removed. Subsequent trials of methylphenidate, titrated to 72 mg every morning, and tramadol, titrated to 100 mg/d, were unsuccessful.

After 10 years of medication and psychotherapy with three different providers, Ms. D’s hair-pulling/eating behaviors persist. She is taking ziprasidone, 120 mg bid, and naltrexone, 100 mg bid, to help her impulse control, as well as sertraline, 300 mg/d, and clomipramine, 125 mg/d. Another trichobezoar removal—her sixth in 8 years—is scheduled.

What strategies exist for minimizing Ms. D’s hair-pulling behavior and keeping her in therapy?

Dr. Lundt’s observations

Trichotillomania’s waxing and waning course—and its destructive effects on a patient’s self-esteem—pose a clinical challenge. The disorder’s severity can range from cosmetically annoying to life-threatening, as in Ms. D’s case. Patients embarrassed by their behavior often prematurely leave treatment, desperate to cut off all social contact—including medical appointments.

It is crucial to maintain a nonjudgmental, inviting demeanor to alleviate the patient’s fears and facilitate a return to treatment. Support groups, especially online, can help decrease patients’ isolation and provide a reliable information network (see Related resources).

 

 

I have had excellent results with other trichotillomania patients—especially children and adolescents. Simply naming their condition and demystifying the problem can be therapeutic. Many patients have responded to SSRIs combined with CBT.

Not long ago, trichotillomania patients were met with ignorance and disbelief within the medical community as the disorder was poorly understood. We need to break this cycle of shame and continue investigating treatment strategies.

Related resources

  • StopPulling.com, an interactive behavioral program for persons with trichotillomania. www.stoppulling.com.
  • Penzel F. The hair pulling problem: a complete guide to trichotillomania. New York: Oxford University Press, 2003.
  • Keuthen NJ, Stein DJ, Christenson GA. Help for hair pullers: understanding and coping with trichotillomania. Oakland, CA: New Harbinger Publications, 2001.

Drug brand names

  • Amitriptyline • Elavil
  • Buspirone • BuSpar
  • Clomipramine • Anafranil
  • Fluoxetine • Prozac
  • Fluvoxamine • Luvox
  • Haloperidol • Haldol
  • Lithium • Eskalith, others
  • Methylphenidate • Concerta, Ritalin
  • Naltrexone • ReVia
  • Olanzapine • Zyprexa
  • Paroxetine • Paxil
  • Pimozide • Orap
  • Quetiapine • Seroquel
  • Risperidone • Risperdal
  • Sertraline • Zoloft
  • Tramadol • Ultram
  • Ziprasidone • Geodon

Disclosure

Dr. Lundt receives research grants from and/or is a speaker for Eli Lilly and Co., Pfizer Inc., GlaxoSmithKline, and Bristol-Myers Squibb Co.

References

1. Mansueto C, Ninan PT, Rothbaum B. Trichotillomania and its treatment in adults: a guide for clinicians. Available at: (http://www.trich.org/articles/view_default.asp?filename="0305_Cases" aid=22&yd= researchers_intro). Accessed April 13, 2004

2. Bouwer C, Stein DJ. Trichobezoars in trichotillomania. Psychosom Med 1998;60:658-60.

3. Philippopoulos GS. A case of trichotillomania (hair pulling). Doc Geigy Acta Psychosom 1961;9:304-12.

4. Lee J. Bezoars and foreign bodies in the stomach. Gastrointest Endosc 1996;6:605-19.

5. Christenson GA, Crow SJ. The characterization and treatment of trichotillomania. Clin Psychiatry 1996;57(suppl 8):42-7.

6. Lal MM, Dhall JC. Trichobezoar: A collective analysis of 39 cases from India with a case report. Indian J Pediatr 1975;12:351-3.

7. DeBakey M, Ochsner W. Bezoars and concretions: A comprehensive review of the literature with an analysis of 303 collected cases and a presentation of 8 additional cases. Surgery 1939;4:934-63.

8. Khouzam HR, Battista MA, Byers PE. An overview of trichotillomania and its response to treatment with quetiapine. Psychiatry 2002;65:261-70.

9. Keuthen NJ, Fraim C, Deckersbach T, et al. Longitudinal follow-up of naturalistic treatment outcome in patients with trichotillomania. J Clin Psychiatry 2001;62:101-7.

10. Swedo SE, Leonard HL, Rapoport JL, et al. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med 1989;8:497-501.

11. van Minnen A, Hoogduin KA, Keijsers GP, et al. Treatment of trichotillomania with behavioral therapy or fluoxetine: a randomized, waiting-list controlled study. Arch Gen Psychiatry 2003;60:517-22.

12. Gabriel A. A case of resistant trichotillomania treated with risperidone-augmented fluvoxamine. Can J Psychiatry 2001;46:285-6.

13. Ravindran AV, Lapierre YD, Anisman H. Obsessive-compulsive spectrum disorders: Effective treatment with paroxetine. Can J Psychiatry 1999;44:805-7.

14. Bradford JM, Gratzer TG. A treatment for impulse control disorders and paraphilia: a case report. Can J Psychiatry 1995;40:4-5.

15. Van Ameringen M, Mancini C, Oakman JM, Farvolden p. The potential role of haloperidol in the treatment of trichotillomania. J Affect Disord 1999;56:219-26.

16. Gupta MA, Gupta AK. Olanzapine is effective in the management of some self-induced dermatoses: Three case reports. Cutis 2000;66:143-6.

17. Stein DJ, Hollander E. Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania. J Clin Psych 1992;53:123-6.

18. Senturk V, Tanriverdi N. Resistant trichotillomania and risperidone. Psychosomatics 2002;43:429-30

19. Christenson GA, Popkin MK, Mackenzie TB, Realmuto GM. Lithium treatment of chronic hair pulling. J Clin Psychiatry 1991;52:116-20.

Article PDF
Author and Disclosure Information

Leslie P. Lundt, MD
Affiliate faculty member Idaho State University, Pocatello, ID Practicing psychiatrist, Boise, ID

Issue
Current Psychiatry - 03(05)
Publications
Topics
Page Number
89-105
Sections
Author and Disclosure Information

Leslie P. Lundt, MD
Affiliate faculty member Idaho State University, Pocatello, ID Practicing psychiatrist, Boise, ID

Author and Disclosure Information

Leslie P. Lundt, MD
Affiliate faculty member Idaho State University, Pocatello, ID Practicing psychiatrist, Boise, ID

Article PDF
Article PDF

History: Bald at age 9

Ms. D, age 41, began compulsively pulling out and eating her hair at age 8. When she didn’t get her way at home or was nervous about school, she would sit for hours, pulling and eating a strand or two at a time, ultimately ingesting a clump of hair.

By age 9, Ms. D was bald. In grade school, she often wore hats and scarves to class to avoid teasing from other children about her baldness. In high school, she kept to herself and frequently wore wigs.

Ms. D stops pulling for brief periods and her hair grows out, but she invariably resumes pulling when psychosocial stressors mount. Many of life’s normal anxieties—job interviews, work-related stress, social rejection—trigger episodes.

When she is bald, Ms. D pulls and eats hair off her wig. Over the years, she has spent thousands of dollars on custom-made wigs that mask her baldness while feeding her habit.

Ms. D’s episodes are increasingly interfering with her life. She has been steadily employed as an office assistant, but does not socialize with coworkers. She has not dated in years, and during an exacerbation leaves home only to go to work. She also pulls her eyelashes and eyebrows and picks her nails and cuticles.

Ms. D first presented in 1994 after seeing a television segment I did on trichotillomania. At intake, she was wearing a wig and exhibited anxious mood. She also has Crohn’s disease; a gastroenterologist monitors her closely.

Ms. D reports compulsive counting and checking but denies other similar behaviors. No immediate family members have exhibited obsessive-compulsive or hair-pulling behaviors. Her father abused alcohol and a sister has a stuttering problem, although Ms. D denies that these have affected her psychologically.

Ms. D’s hair-pulling behavior suggests:

  • a pica disorder
  • an impulse control disorder
  • or an obsessive-compulsive disorder?

Box

DSM-IV-TR diagnostic criteria for trichotillomania

  1. Recurrent pulling out of one’s own hair, resulting in noticeable hair loss.
  2. Increasing tension immediately before pulling out the hair or when attempting to resist the behavior.
  3. Pleasure, gratification, or relief while pulling out the hair.
  4. The disturbance is not better explained as another mental disorder and is not caused by a dermatological or other general medical condition.
  5. The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.

Source: Reprinted with permission from the Diagnostic and statistical manual of mental disorders, 4th ed., text revision. Copyright 2000. American Psychiatric Association.

Dr. Lundt’s observations

Trichotillomania, defined as compulsive pulling of hair, usually begins in childhood or adolescence. Scalp hair is most commonly pulled, but some patients also pull their eyelashes, pubic hair, and other body hair. Some, especially children, have reportedly pulled their pets’ hair.

Mansueto et al estimate that trichotillomania afflicts approximately 1.5% of males and 3.5% of females.1 These estimates, however, do not include persons with the disorder who are too embarrassed to seek treatment.

DSM-IV-TR classifies trichotillomania as an impulse control disorder (Box). Although comorbid anxiety and depressive disorders are common, Ms. D did not meet criteria for any other psychiatric disorder.

Trichotillomania often is episodic. Months or years of abstinence is common after periods of exacerbation, usually caused by stress (Figure).

Many clinicians mistakenly consider trichotillomania a benign disorder with few consequences beyond alopecia.2 Some patients, however, progress into trichophagia—ingestion of pulled hair. Trichophagia is a form of pica disorder, typically defined as persistent eating of non-nutritive substances. Patients often harbor tremendous shame over their hair-eating behavior and resist psychiatric or medical treatment.2

The undigested hair can form sometimes massive clumps called trichobezoars, which are most common among children and the developmentally disabled.4 Persons with trichophagia face a 37.5% risk of forming a trichobezoar.5 The mass can cause abdominal pain, nausea, vomiting, and weight loss; complications include GI obstruction, ulceration, perforation, and peritonitis.6 An untreated trichobezoar can be fatal,7 although such deaths are rare among patients being treated for trichotillomania.

Patients with trichotillomania often respond to medications used to treat obsessive-compulsive disorder, such as clomipramine. Some clinicians believe this agent is more effective than selective serotonin reuptake inhibitors (SSRIs) but more difficult to tolerate. For Ms. D, I started with both.

Treatment: ‘I Don’t need medication’

Initial treatments—including fluoxetine, 20 mg/d for 6 months; hypnotherapy; and clomipramine, 25 mg/d—were unsuccessful. Ms. D was only marginally compliant, believing that she did not need medication.

I referred Ms. D to an out-of-state residential behavioral program specializing in trichotillomania, but she refused to go even as her hair-pulling intensified. Clomipramine was gradually increased to 75 mg nightly, briefly decreasing her pulling, then to 100 mg nightly when symptoms re-emerged. Clomipramine blood levels were monitored with each dosage change to guard against CNS and cardiac toxicity and other side effects (GI complaints, dizziness, cardiac arrhythmias, somnolence).

 

 

After watching for seasonal patterns, I found that Ms. D’s hair-pulling worsened during the winter, although no seasonal change in mood was detected. Phototherapy produced initial success, but Ms. D continued to pull her eyelashes.

Eight weeks later, however, Ms. D’s symptoms escalated. Clomipramine was increased to 150 mg nightly, resulting in blood levels of 99 ng/mL for clomipramine and 204 ng/mL for the metabolite N-desmethylclomipramine—both within the therapeutic range. As she continued pulling, I added buspirone, 10 mg/d.

At this point, would you:

  • continue clomipramine and increase the dosage?
  • discontinue clomipramine and start another psychotropic?
  • or maintain clomipramine at the same dosage and add another psychotropic?

Dr. Lundt’s observations

Drug treatment of trichotillomania has not been studied extensively or long-term, and no consensus exists. Psychoanalysis, cognitive-behavioral therapy (CBT), and hypnotherapy are usually administered with psychotropics.8 Patients often respond to treatment at first, then reach a plateau and resume pulling their hair.9

Numerous psychotropics are used off-label to treat trichotillomania. Several agents have been shown in clinical trials and case reports to reduce hair pulling/eating behaviors (Table), but these findings are limited by small sample size, lack of control groups, and lack of a standard symptom rating scale.

Figure Trichotillomania: Excessive grooming, habit, or vicious circle?



Most clinicians begin with SSRIs because they are generally well tolerated, even at high dosages. Monotherapy often is not adequate for trichotillomania, however. Medication augmentation is common, although little empiric data support this practice.

When clomipramine did not work initally, I explored serotonergic combination strategies.

Table

Medications shown to benefit patients with trichotillomania

DrugEvidenceDosage range (mg/d)Potential side effects
First-line
Tricyclic
 ClomipramineSwedo et al10 50 to 300Sedation, weight gain, cardiac arrythmias
SSRIs
 Fluoxetinevan Minnen et al11 20 to 60GI symptoms, insomnia
 FluvoxamineGabriel12 50 to 250Sexual dysfunction, weight gain
 ParoxetineRavindran et al13 20 to 60Sexual dysfunction, weight gain
 SertralineBradford and Gratzer14 50 to 200Sexual dysfunction, GI symptoms, insomnia
Second-line
Antipsychotics
 HaloperidolVan Ameringen et al15 0.25 to 2Sedation, EPS
 OlanzapineGupta and Gupta16 2.5 to 10Sedation, weight gain
 PimozideStein and Hollander17 25 to 200Restlessness, EPS
 QuetiapineKhouzam et al8 25 to 200Sedation
 RisperidoneGabriel12 Senturk and Tanriverdi18 0.5 to 4.0Sedation, hyperprolactinemia
Mood stabilizer
 LithiumChristenson et al19 900 to 1,500Increased thirst, weight gain, tremor
EPS: extrapyramidal symptoms

Further treatment: Relapse, resection

Ms. D was lost to follow-up for 1 year. She returned in 1996, just after undergoing a laparotomy for removal of a trichobezoar large enough to fill two 2-inch-by-6-inch bags. She also had been treated for pneumonia and a pulmonary embolus.

Riddled with shame and embarrassment, Ms. D had stopped pulling for 10 months, during which time she was off medication. Her pulling behaviors re-emerged, however, and clomipramine was restarted and titrated to 250 mg nightly.

One year later, a second trichobezoar was resected. Her clomipramine/N-desmethylclomipramine level reached 1,535 ng/mL, although an ECG reading was normal. Subsequent clomipramine/N-desmethylclomipramine blood levels were within the therapeutic range. Fluvoxamine, 25 mg/d titrated across 6 weeks to 150 mg/d, was added.

Again, Ms. D stopped taking her medications and was lost to follow-up. Her gastroenterologist began managing her care and started sertraline, dosage unknown, to address her depressed mood. A third trichobezoar was removed.

When Ms. D returned to my practice, I resumed CBT and increased sertraline over 1 month from 100 to 300 mg/d. Adding olanzapine, 2.5 mg/d, diminished her anxiety and markedly decreased her hair pulling.

Months later, her hair-pulling/eating behaviors again intensified, resulting in a small-bowel obstruction and a fourth trichobezoar removal. Olanzapine was increased to 5 mg nightly without significant benefit and with sedating effects.

Clomipramine, 125 mg/d, was reintroduced and her symptoms improved dramatically. On a regimen of sertraline, clomipramine and olanzapine, Ms. D remained stable for 2 years.

Last year, however, a fifth trichobezoar measuring 20 x 15 cm was removed. Subsequent trials of methylphenidate, titrated to 72 mg every morning, and tramadol, titrated to 100 mg/d, were unsuccessful.

After 10 years of medication and psychotherapy with three different providers, Ms. D’s hair-pulling/eating behaviors persist. She is taking ziprasidone, 120 mg bid, and naltrexone, 100 mg bid, to help her impulse control, as well as sertraline, 300 mg/d, and clomipramine, 125 mg/d. Another trichobezoar removal—her sixth in 8 years—is scheduled.

What strategies exist for minimizing Ms. D’s hair-pulling behavior and keeping her in therapy?

Dr. Lundt’s observations

Trichotillomania’s waxing and waning course—and its destructive effects on a patient’s self-esteem—pose a clinical challenge. The disorder’s severity can range from cosmetically annoying to life-threatening, as in Ms. D’s case. Patients embarrassed by their behavior often prematurely leave treatment, desperate to cut off all social contact—including medical appointments.

It is crucial to maintain a nonjudgmental, inviting demeanor to alleviate the patient’s fears and facilitate a return to treatment. Support groups, especially online, can help decrease patients’ isolation and provide a reliable information network (see Related resources).

 

 

I have had excellent results with other trichotillomania patients—especially children and adolescents. Simply naming their condition and demystifying the problem can be therapeutic. Many patients have responded to SSRIs combined with CBT.

Not long ago, trichotillomania patients were met with ignorance and disbelief within the medical community as the disorder was poorly understood. We need to break this cycle of shame and continue investigating treatment strategies.

Related resources

  • StopPulling.com, an interactive behavioral program for persons with trichotillomania. www.stoppulling.com.
  • Penzel F. The hair pulling problem: a complete guide to trichotillomania. New York: Oxford University Press, 2003.
  • Keuthen NJ, Stein DJ, Christenson GA. Help for hair pullers: understanding and coping with trichotillomania. Oakland, CA: New Harbinger Publications, 2001.

Drug brand names

  • Amitriptyline • Elavil
  • Buspirone • BuSpar
  • Clomipramine • Anafranil
  • Fluoxetine • Prozac
  • Fluvoxamine • Luvox
  • Haloperidol • Haldol
  • Lithium • Eskalith, others
  • Methylphenidate • Concerta, Ritalin
  • Naltrexone • ReVia
  • Olanzapine • Zyprexa
  • Paroxetine • Paxil
  • Pimozide • Orap
  • Quetiapine • Seroquel
  • Risperidone • Risperdal
  • Sertraline • Zoloft
  • Tramadol • Ultram
  • Ziprasidone • Geodon

Disclosure

Dr. Lundt receives research grants from and/or is a speaker for Eli Lilly and Co., Pfizer Inc., GlaxoSmithKline, and Bristol-Myers Squibb Co.

History: Bald at age 9

Ms. D, age 41, began compulsively pulling out and eating her hair at age 8. When she didn’t get her way at home or was nervous about school, she would sit for hours, pulling and eating a strand or two at a time, ultimately ingesting a clump of hair.

By age 9, Ms. D was bald. In grade school, she often wore hats and scarves to class to avoid teasing from other children about her baldness. In high school, she kept to herself and frequently wore wigs.

Ms. D stops pulling for brief periods and her hair grows out, but she invariably resumes pulling when psychosocial stressors mount. Many of life’s normal anxieties—job interviews, work-related stress, social rejection—trigger episodes.

When she is bald, Ms. D pulls and eats hair off her wig. Over the years, she has spent thousands of dollars on custom-made wigs that mask her baldness while feeding her habit.

Ms. D’s episodes are increasingly interfering with her life. She has been steadily employed as an office assistant, but does not socialize with coworkers. She has not dated in years, and during an exacerbation leaves home only to go to work. She also pulls her eyelashes and eyebrows and picks her nails and cuticles.

Ms. D first presented in 1994 after seeing a television segment I did on trichotillomania. At intake, she was wearing a wig and exhibited anxious mood. She also has Crohn’s disease; a gastroenterologist monitors her closely.

Ms. D reports compulsive counting and checking but denies other similar behaviors. No immediate family members have exhibited obsessive-compulsive or hair-pulling behaviors. Her father abused alcohol and a sister has a stuttering problem, although Ms. D denies that these have affected her psychologically.

Ms. D’s hair-pulling behavior suggests:

  • a pica disorder
  • an impulse control disorder
  • or an obsessive-compulsive disorder?

Box

DSM-IV-TR diagnostic criteria for trichotillomania

  1. Recurrent pulling out of one’s own hair, resulting in noticeable hair loss.
  2. Increasing tension immediately before pulling out the hair or when attempting to resist the behavior.
  3. Pleasure, gratification, or relief while pulling out the hair.
  4. The disturbance is not better explained as another mental disorder and is not caused by a dermatological or other general medical condition.
  5. The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.

Source: Reprinted with permission from the Diagnostic and statistical manual of mental disorders, 4th ed., text revision. Copyright 2000. American Psychiatric Association.

Dr. Lundt’s observations

Trichotillomania, defined as compulsive pulling of hair, usually begins in childhood or adolescence. Scalp hair is most commonly pulled, but some patients also pull their eyelashes, pubic hair, and other body hair. Some, especially children, have reportedly pulled their pets’ hair.

Mansueto et al estimate that trichotillomania afflicts approximately 1.5% of males and 3.5% of females.1 These estimates, however, do not include persons with the disorder who are too embarrassed to seek treatment.

DSM-IV-TR classifies trichotillomania as an impulse control disorder (Box). Although comorbid anxiety and depressive disorders are common, Ms. D did not meet criteria for any other psychiatric disorder.

Trichotillomania often is episodic. Months or years of abstinence is common after periods of exacerbation, usually caused by stress (Figure).

Many clinicians mistakenly consider trichotillomania a benign disorder with few consequences beyond alopecia.2 Some patients, however, progress into trichophagia—ingestion of pulled hair. Trichophagia is a form of pica disorder, typically defined as persistent eating of non-nutritive substances. Patients often harbor tremendous shame over their hair-eating behavior and resist psychiatric or medical treatment.2

The undigested hair can form sometimes massive clumps called trichobezoars, which are most common among children and the developmentally disabled.4 Persons with trichophagia face a 37.5% risk of forming a trichobezoar.5 The mass can cause abdominal pain, nausea, vomiting, and weight loss; complications include GI obstruction, ulceration, perforation, and peritonitis.6 An untreated trichobezoar can be fatal,7 although such deaths are rare among patients being treated for trichotillomania.

Patients with trichotillomania often respond to medications used to treat obsessive-compulsive disorder, such as clomipramine. Some clinicians believe this agent is more effective than selective serotonin reuptake inhibitors (SSRIs) but more difficult to tolerate. For Ms. D, I started with both.

Treatment: ‘I Don’t need medication’

Initial treatments—including fluoxetine, 20 mg/d for 6 months; hypnotherapy; and clomipramine, 25 mg/d—were unsuccessful. Ms. D was only marginally compliant, believing that she did not need medication.

I referred Ms. D to an out-of-state residential behavioral program specializing in trichotillomania, but she refused to go even as her hair-pulling intensified. Clomipramine was gradually increased to 75 mg nightly, briefly decreasing her pulling, then to 100 mg nightly when symptoms re-emerged. Clomipramine blood levels were monitored with each dosage change to guard against CNS and cardiac toxicity and other side effects (GI complaints, dizziness, cardiac arrhythmias, somnolence).

 

 

After watching for seasonal patterns, I found that Ms. D’s hair-pulling worsened during the winter, although no seasonal change in mood was detected. Phototherapy produced initial success, but Ms. D continued to pull her eyelashes.

Eight weeks later, however, Ms. D’s symptoms escalated. Clomipramine was increased to 150 mg nightly, resulting in blood levels of 99 ng/mL for clomipramine and 204 ng/mL for the metabolite N-desmethylclomipramine—both within the therapeutic range. As she continued pulling, I added buspirone, 10 mg/d.

At this point, would you:

  • continue clomipramine and increase the dosage?
  • discontinue clomipramine and start another psychotropic?
  • or maintain clomipramine at the same dosage and add another psychotropic?

Dr. Lundt’s observations

Drug treatment of trichotillomania has not been studied extensively or long-term, and no consensus exists. Psychoanalysis, cognitive-behavioral therapy (CBT), and hypnotherapy are usually administered with psychotropics.8 Patients often respond to treatment at first, then reach a plateau and resume pulling their hair.9

Numerous psychotropics are used off-label to treat trichotillomania. Several agents have been shown in clinical trials and case reports to reduce hair pulling/eating behaviors (Table), but these findings are limited by small sample size, lack of control groups, and lack of a standard symptom rating scale.

Figure Trichotillomania: Excessive grooming, habit, or vicious circle?



Most clinicians begin with SSRIs because they are generally well tolerated, even at high dosages. Monotherapy often is not adequate for trichotillomania, however. Medication augmentation is common, although little empiric data support this practice.

When clomipramine did not work initally, I explored serotonergic combination strategies.

Table

Medications shown to benefit patients with trichotillomania

DrugEvidenceDosage range (mg/d)Potential side effects
First-line
Tricyclic
 ClomipramineSwedo et al10 50 to 300Sedation, weight gain, cardiac arrythmias
SSRIs
 Fluoxetinevan Minnen et al11 20 to 60GI symptoms, insomnia
 FluvoxamineGabriel12 50 to 250Sexual dysfunction, weight gain
 ParoxetineRavindran et al13 20 to 60Sexual dysfunction, weight gain
 SertralineBradford and Gratzer14 50 to 200Sexual dysfunction, GI symptoms, insomnia
Second-line
Antipsychotics
 HaloperidolVan Ameringen et al15 0.25 to 2Sedation, EPS
 OlanzapineGupta and Gupta16 2.5 to 10Sedation, weight gain
 PimozideStein and Hollander17 25 to 200Restlessness, EPS
 QuetiapineKhouzam et al8 25 to 200Sedation
 RisperidoneGabriel12 Senturk and Tanriverdi18 0.5 to 4.0Sedation, hyperprolactinemia
Mood stabilizer
 LithiumChristenson et al19 900 to 1,500Increased thirst, weight gain, tremor
EPS: extrapyramidal symptoms

Further treatment: Relapse, resection

Ms. D was lost to follow-up for 1 year. She returned in 1996, just after undergoing a laparotomy for removal of a trichobezoar large enough to fill two 2-inch-by-6-inch bags. She also had been treated for pneumonia and a pulmonary embolus.

Riddled with shame and embarrassment, Ms. D had stopped pulling for 10 months, during which time she was off medication. Her pulling behaviors re-emerged, however, and clomipramine was restarted and titrated to 250 mg nightly.

One year later, a second trichobezoar was resected. Her clomipramine/N-desmethylclomipramine level reached 1,535 ng/mL, although an ECG reading was normal. Subsequent clomipramine/N-desmethylclomipramine blood levels were within the therapeutic range. Fluvoxamine, 25 mg/d titrated across 6 weeks to 150 mg/d, was added.

Again, Ms. D stopped taking her medications and was lost to follow-up. Her gastroenterologist began managing her care and started sertraline, dosage unknown, to address her depressed mood. A third trichobezoar was removed.

When Ms. D returned to my practice, I resumed CBT and increased sertraline over 1 month from 100 to 300 mg/d. Adding olanzapine, 2.5 mg/d, diminished her anxiety and markedly decreased her hair pulling.

Months later, her hair-pulling/eating behaviors again intensified, resulting in a small-bowel obstruction and a fourth trichobezoar removal. Olanzapine was increased to 5 mg nightly without significant benefit and with sedating effects.

Clomipramine, 125 mg/d, was reintroduced and her symptoms improved dramatically. On a regimen of sertraline, clomipramine and olanzapine, Ms. D remained stable for 2 years.

Last year, however, a fifth trichobezoar measuring 20 x 15 cm was removed. Subsequent trials of methylphenidate, titrated to 72 mg every morning, and tramadol, titrated to 100 mg/d, were unsuccessful.

After 10 years of medication and psychotherapy with three different providers, Ms. D’s hair-pulling/eating behaviors persist. She is taking ziprasidone, 120 mg bid, and naltrexone, 100 mg bid, to help her impulse control, as well as sertraline, 300 mg/d, and clomipramine, 125 mg/d. Another trichobezoar removal—her sixth in 8 years—is scheduled.

What strategies exist for minimizing Ms. D’s hair-pulling behavior and keeping her in therapy?

Dr. Lundt’s observations

Trichotillomania’s waxing and waning course—and its destructive effects on a patient’s self-esteem—pose a clinical challenge. The disorder’s severity can range from cosmetically annoying to life-threatening, as in Ms. D’s case. Patients embarrassed by their behavior often prematurely leave treatment, desperate to cut off all social contact—including medical appointments.

It is crucial to maintain a nonjudgmental, inviting demeanor to alleviate the patient’s fears and facilitate a return to treatment. Support groups, especially online, can help decrease patients’ isolation and provide a reliable information network (see Related resources).

 

 

I have had excellent results with other trichotillomania patients—especially children and adolescents. Simply naming their condition and demystifying the problem can be therapeutic. Many patients have responded to SSRIs combined with CBT.

Not long ago, trichotillomania patients were met with ignorance and disbelief within the medical community as the disorder was poorly understood. We need to break this cycle of shame and continue investigating treatment strategies.

Related resources

  • StopPulling.com, an interactive behavioral program for persons with trichotillomania. www.stoppulling.com.
  • Penzel F. The hair pulling problem: a complete guide to trichotillomania. New York: Oxford University Press, 2003.
  • Keuthen NJ, Stein DJ, Christenson GA. Help for hair pullers: understanding and coping with trichotillomania. Oakland, CA: New Harbinger Publications, 2001.

Drug brand names

  • Amitriptyline • Elavil
  • Buspirone • BuSpar
  • Clomipramine • Anafranil
  • Fluoxetine • Prozac
  • Fluvoxamine • Luvox
  • Haloperidol • Haldol
  • Lithium • Eskalith, others
  • Methylphenidate • Concerta, Ritalin
  • Naltrexone • ReVia
  • Olanzapine • Zyprexa
  • Paroxetine • Paxil
  • Pimozide • Orap
  • Quetiapine • Seroquel
  • Risperidone • Risperdal
  • Sertraline • Zoloft
  • Tramadol • Ultram
  • Ziprasidone • Geodon

Disclosure

Dr. Lundt receives research grants from and/or is a speaker for Eli Lilly and Co., Pfizer Inc., GlaxoSmithKline, and Bristol-Myers Squibb Co.

References

1. Mansueto C, Ninan PT, Rothbaum B. Trichotillomania and its treatment in adults: a guide for clinicians. Available at: (http://www.trich.org/articles/view_default.asp?filename="0305_Cases" aid=22&yd= researchers_intro). Accessed April 13, 2004

2. Bouwer C, Stein DJ. Trichobezoars in trichotillomania. Psychosom Med 1998;60:658-60.

3. Philippopoulos GS. A case of trichotillomania (hair pulling). Doc Geigy Acta Psychosom 1961;9:304-12.

4. Lee J. Bezoars and foreign bodies in the stomach. Gastrointest Endosc 1996;6:605-19.

5. Christenson GA, Crow SJ. The characterization and treatment of trichotillomania. Clin Psychiatry 1996;57(suppl 8):42-7.

6. Lal MM, Dhall JC. Trichobezoar: A collective analysis of 39 cases from India with a case report. Indian J Pediatr 1975;12:351-3.

7. DeBakey M, Ochsner W. Bezoars and concretions: A comprehensive review of the literature with an analysis of 303 collected cases and a presentation of 8 additional cases. Surgery 1939;4:934-63.

8. Khouzam HR, Battista MA, Byers PE. An overview of trichotillomania and its response to treatment with quetiapine. Psychiatry 2002;65:261-70.

9. Keuthen NJ, Fraim C, Deckersbach T, et al. Longitudinal follow-up of naturalistic treatment outcome in patients with trichotillomania. J Clin Psychiatry 2001;62:101-7.

10. Swedo SE, Leonard HL, Rapoport JL, et al. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med 1989;8:497-501.

11. van Minnen A, Hoogduin KA, Keijsers GP, et al. Treatment of trichotillomania with behavioral therapy or fluoxetine: a randomized, waiting-list controlled study. Arch Gen Psychiatry 2003;60:517-22.

12. Gabriel A. A case of resistant trichotillomania treated with risperidone-augmented fluvoxamine. Can J Psychiatry 2001;46:285-6.

13. Ravindran AV, Lapierre YD, Anisman H. Obsessive-compulsive spectrum disorders: Effective treatment with paroxetine. Can J Psychiatry 1999;44:805-7.

14. Bradford JM, Gratzer TG. A treatment for impulse control disorders and paraphilia: a case report. Can J Psychiatry 1995;40:4-5.

15. Van Ameringen M, Mancini C, Oakman JM, Farvolden p. The potential role of haloperidol in the treatment of trichotillomania. J Affect Disord 1999;56:219-26.

16. Gupta MA, Gupta AK. Olanzapine is effective in the management of some self-induced dermatoses: Three case reports. Cutis 2000;66:143-6.

17. Stein DJ, Hollander E. Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania. J Clin Psych 1992;53:123-6.

18. Senturk V, Tanriverdi N. Resistant trichotillomania and risperidone. Psychosomatics 2002;43:429-30

19. Christenson GA, Popkin MK, Mackenzie TB, Realmuto GM. Lithium treatment of chronic hair pulling. J Clin Psychiatry 1991;52:116-20.

References

1. Mansueto C, Ninan PT, Rothbaum B. Trichotillomania and its treatment in adults: a guide for clinicians. Available at: (http://www.trich.org/articles/view_default.asp?filename="0305_Cases" aid=22&yd= researchers_intro). Accessed April 13, 2004

2. Bouwer C, Stein DJ. Trichobezoars in trichotillomania. Psychosom Med 1998;60:658-60.

3. Philippopoulos GS. A case of trichotillomania (hair pulling). Doc Geigy Acta Psychosom 1961;9:304-12.

4. Lee J. Bezoars and foreign bodies in the stomach. Gastrointest Endosc 1996;6:605-19.

5. Christenson GA, Crow SJ. The characterization and treatment of trichotillomania. Clin Psychiatry 1996;57(suppl 8):42-7.

6. Lal MM, Dhall JC. Trichobezoar: A collective analysis of 39 cases from India with a case report. Indian J Pediatr 1975;12:351-3.

7. DeBakey M, Ochsner W. Bezoars and concretions: A comprehensive review of the literature with an analysis of 303 collected cases and a presentation of 8 additional cases. Surgery 1939;4:934-63.

8. Khouzam HR, Battista MA, Byers PE. An overview of trichotillomania and its response to treatment with quetiapine. Psychiatry 2002;65:261-70.

9. Keuthen NJ, Fraim C, Deckersbach T, et al. Longitudinal follow-up of naturalistic treatment outcome in patients with trichotillomania. J Clin Psychiatry 2001;62:101-7.

10. Swedo SE, Leonard HL, Rapoport JL, et al. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med 1989;8:497-501.

11. van Minnen A, Hoogduin KA, Keijsers GP, et al. Treatment of trichotillomania with behavioral therapy or fluoxetine: a randomized, waiting-list controlled study. Arch Gen Psychiatry 2003;60:517-22.

12. Gabriel A. A case of resistant trichotillomania treated with risperidone-augmented fluvoxamine. Can J Psychiatry 2001;46:285-6.

13. Ravindran AV, Lapierre YD, Anisman H. Obsessive-compulsive spectrum disorders: Effective treatment with paroxetine. Can J Psychiatry 1999;44:805-7.

14. Bradford JM, Gratzer TG. A treatment for impulse control disorders and paraphilia: a case report. Can J Psychiatry 1995;40:4-5.

15. Van Ameringen M, Mancini C, Oakman JM, Farvolden p. The potential role of haloperidol in the treatment of trichotillomania. J Affect Disord 1999;56:219-26.

16. Gupta MA, Gupta AK. Olanzapine is effective in the management of some self-induced dermatoses: Three case reports. Cutis 2000;66:143-6.

17. Stein DJ, Hollander E. Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania. J Clin Psych 1992;53:123-6.

18. Senturk V, Tanriverdi N. Resistant trichotillomania and risperidone. Psychosomatics 2002;43:429-30

19. Christenson GA, Popkin MK, Mackenzie TB, Realmuto GM. Lithium treatment of chronic hair pulling. J Clin Psychiatry 1991;52:116-20.

Issue
Current Psychiatry - 03(05)
Issue
Current Psychiatry - 03(05)
Page Number
89-105
Page Number
89-105
Publications
Publications
Topics
Article Type
Display Headline
Trichotillomania: A heads-up on severe cases
Display Headline
Trichotillomania: A heads-up on severe cases
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Annual proteinuria screening not cost-effective

Article Type
Changed
Fri, 01/18/2019 - 08:40
Display Headline
Annual proteinuria screening not cost-effective
BOTTOM LINE

Annual screening of adults to detect proteinuria and prevent end-stage renal disease (ESRD) is not cost-effective unless directed only at high-risk groups (that is, those patients with diabetes and hypertension). Screening every 10 years beginning at the age 60 years, however, is highly cost-effective. (LOE=1b)

 
Article PDF
Author and Disclosure Information

Practice Recommendations from Key Studies

Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in US adults. A cost-effective analysis. JAMA 2003; 290:3101–3114.

Issue
The Journal of Family Practice - 53(4)
Publications
Topics
Page Number
261-268
Sections
Author and Disclosure Information

Practice Recommendations from Key Studies

Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in US adults. A cost-effective analysis. JAMA 2003; 290:3101–3114.

Author and Disclosure Information

Practice Recommendations from Key Studies

Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in US adults. A cost-effective analysis. JAMA 2003; 290:3101–3114.

Article PDF
Article PDF
BOTTOM LINE

Annual screening of adults to detect proteinuria and prevent end-stage renal disease (ESRD) is not cost-effective unless directed only at high-risk groups (that is, those patients with diabetes and hypertension). Screening every 10 years beginning at the age 60 years, however, is highly cost-effective. (LOE=1b)

 
BOTTOM LINE

Annual screening of adults to detect proteinuria and prevent end-stage renal disease (ESRD) is not cost-effective unless directed only at high-risk groups (that is, those patients with diabetes and hypertension). Screening every 10 years beginning at the age 60 years, however, is highly cost-effective. (LOE=1b)

 
Issue
The Journal of Family Practice - 53(4)
Issue
The Journal of Family Practice - 53(4)
Page Number
261-268
Page Number
261-268
Publications
Publications
Topics
Article Type
Display Headline
Annual proteinuria screening not cost-effective
Display Headline
Annual proteinuria screening not cost-effective
Sections
Disallow All Ads
Article PDF Media

Hypoglycemia in diabetes: Common, often unrecognized

Article Type
Changed
Tue, 05/03/2022 - 16:10
Display Headline
Hypoglycemia in diabetes: Common, often unrecognized
Article PDF
Author and Disclosure Information

Ilan Gabriely, MD
Diabetes Research Center, Albert Einstein College of Medicine, New York

Harry Shamoon, MD
Professor of Medicine, Diabetes Research Center, Albert Einstein College of Medicine, New York

Address: Harry Shamoon, MD, Professor of Medicine, Diabetes Research Center, Albert Einstein College of Medicine, Belfer Building 706, 1300 Morris Park Avenue, Bronx, NY 10461; e-mail shamoon@aecom.yu.edu

Issue
Cleveland Clinic Journal of Medicine - 71(4)
Publications
Topics
Page Number
335-342
Sections
Author and Disclosure Information

Ilan Gabriely, MD
Diabetes Research Center, Albert Einstein College of Medicine, New York

Harry Shamoon, MD
Professor of Medicine, Diabetes Research Center, Albert Einstein College of Medicine, New York

Address: Harry Shamoon, MD, Professor of Medicine, Diabetes Research Center, Albert Einstein College of Medicine, Belfer Building 706, 1300 Morris Park Avenue, Bronx, NY 10461; e-mail shamoon@aecom.yu.edu

Author and Disclosure Information

Ilan Gabriely, MD
Diabetes Research Center, Albert Einstein College of Medicine, New York

Harry Shamoon, MD
Professor of Medicine, Diabetes Research Center, Albert Einstein College of Medicine, New York

Address: Harry Shamoon, MD, Professor of Medicine, Diabetes Research Center, Albert Einstein College of Medicine, Belfer Building 706, 1300 Morris Park Avenue, Bronx, NY 10461; e-mail shamoon@aecom.yu.edu

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 71(4)
Issue
Cleveland Clinic Journal of Medicine - 71(4)
Page Number
335-342
Page Number
335-342
Publications
Publications
Topics
Article Type
Display Headline
Hypoglycemia in diabetes: Common, often unrecognized
Display Headline
Hypoglycemia in diabetes: Common, often unrecognized
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Hypoglycemia

Article Type
Changed
Tue, 05/03/2022 - 16:10
Display Headline
Hypoglycemia
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 71(4)
Publications
Topics
Page Number
343-344
Sections
Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 71(4)
Issue
Cleveland Clinic Journal of Medicine - 71(4)
Page Number
343-344
Page Number
343-344
Publications
Publications
Topics
Article Type
Display Headline
Hypoglycemia
Display Headline
Hypoglycemia
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

What is premenstrual dysphoric disorder (PMDD)?

Article Type
Changed
Fri, 10/05/2018 - 06:58
Display Headline
What is premenstrual dysphoric disorder (PMDD)?
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 71(4)
Publications
Topics
Page Number
322
Sections
Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 71(4)
Issue
Cleveland Clinic Journal of Medicine - 71(4)
Page Number
322
Page Number
322
Publications
Publications
Topics
Article Type
Display Headline
What is premenstrual dysphoric disorder (PMDD)?
Display Headline
What is premenstrual dysphoric disorder (PMDD)?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Minimally invasive surgery for morbid obesity

Article Type
Changed
Fri, 10/05/2018 - 06:49
Display Headline
Minimally invasive surgery for morbid obesity
Article PDF
Author and Disclosure Information

Fredrick Brody, MD
Associate Professor of Surgery, Director of Minimally Invasive Surgery, The George Washington University Medical Center,Washington, DC

Address: Fredrick Brody, MD, The George Washington University Medical Center, Department of Surgery, Suite 6B, 2150 Pennsylvania Avenue, NW, Washington, DC 20037; e-mail fbrody@mfa.gwu.edu

Issue
Cleveland Clinic Journal of Medicine - 71(4)
Publications
Topics
Page Number
289, 293, 296-298
Sections
Author and Disclosure Information

Fredrick Brody, MD
Associate Professor of Surgery, Director of Minimally Invasive Surgery, The George Washington University Medical Center,Washington, DC

Address: Fredrick Brody, MD, The George Washington University Medical Center, Department of Surgery, Suite 6B, 2150 Pennsylvania Avenue, NW, Washington, DC 20037; e-mail fbrody@mfa.gwu.edu

Author and Disclosure Information

Fredrick Brody, MD
Associate Professor of Surgery, Director of Minimally Invasive Surgery, The George Washington University Medical Center,Washington, DC

Address: Fredrick Brody, MD, The George Washington University Medical Center, Department of Surgery, Suite 6B, 2150 Pennsylvania Avenue, NW, Washington, DC 20037; e-mail fbrody@mfa.gwu.edu

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 71(4)
Issue
Cleveland Clinic Journal of Medicine - 71(4)
Page Number
289, 293, 296-298
Page Number
289, 293, 296-298
Publications
Publications
Topics
Article Type
Display Headline
Minimally invasive surgery for morbid obesity
Display Headline
Minimally invasive surgery for morbid obesity
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

For low platelets, how low is dangerous?

Article Type
Changed
Fri, 10/05/2018 - 06:35
Display Headline
For low platelets, how low is dangerous?
Article PDF
Author and Disclosure Information

James N. George, MD
Hematology-Oncology Section, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City

Address: James N. George, MD, The University of Oklahoma Health Sciences Center, Hematology-Oncology Section, Room ET, EB-271, PO Box 26901, Oklahoma City, OK 73190; e-mail james-george@ouhsc.edu

Issue
Cleveland Clinic Journal of Medicine - 71(4)
Publications
Topics
Page Number
277-278
Sections
Author and Disclosure Information

James N. George, MD
Hematology-Oncology Section, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City

Address: James N. George, MD, The University of Oklahoma Health Sciences Center, Hematology-Oncology Section, Room ET, EB-271, PO Box 26901, Oklahoma City, OK 73190; e-mail james-george@ouhsc.edu

Author and Disclosure Information

James N. George, MD
Hematology-Oncology Section, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City

Address: James N. George, MD, The University of Oklahoma Health Sciences Center, Hematology-Oncology Section, Room ET, EB-271, PO Box 26901, Oklahoma City, OK 73190; e-mail james-george@ouhsc.edu

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 71(4)
Issue
Cleveland Clinic Journal of Medicine - 71(4)
Page Number
277-278
Page Number
277-278
Publications
Publications
Topics
Article Type
Display Headline
For low platelets, how low is dangerous?
Display Headline
For low platelets, how low is dangerous?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Avian influenza: A wake-up call from birds to humans

Article Type
Changed
Fri, 10/05/2018 - 06:33
Display Headline
Avian influenza: A wake-up call from birds to humans
Article PDF
Author and Disclosure Information

Steven Gordon, MD
Department of Infectious Diseases, The Cleveland Clinic Foundation

Issue
Cleveland Clinic Journal of Medicine - 71(4)
Publications
Topics
Page Number
273-274
Sections
Author and Disclosure Information

Steven Gordon, MD
Department of Infectious Diseases, The Cleveland Clinic Foundation

Author and Disclosure Information

Steven Gordon, MD
Department of Infectious Diseases, The Cleveland Clinic Foundation

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 71(4)
Issue
Cleveland Clinic Journal of Medicine - 71(4)
Page Number
273-274
Page Number
273-274
Publications
Publications
Topics
Article Type
Display Headline
Avian influenza: A wake-up call from birds to humans
Display Headline
Avian influenza: A wake-up call from birds to humans
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Psoriasis: The Lymphoma Link

Article Type
Changed
Thu, 12/15/2022 - 15:15
Display Headline
Psoriasis: The Lymphoma Link
Article PDF
Author and Disclosure Information

 

 

Issue
Federal Practitioner - 21(4)
Publications
Topics
Page Number
88
Legacy Keywords
cancer, dermatology, psoriasis, lymphomacancer, dermatology, psoriasis, lymphoma
Sections
Author and Disclosure Information

 

 

Author and Disclosure Information

 

 

Article PDF
Article PDF
Issue
Federal Practitioner - 21(4)
Issue
Federal Practitioner - 21(4)
Page Number
88
Page Number
88
Publications
Publications
Topics
Article Type
Display Headline
Psoriasis: The Lymphoma Link
Display Headline
Psoriasis: The Lymphoma Link
Legacy Keywords
cancer, dermatology, psoriasis, lymphomacancer, dermatology, psoriasis, lymphoma
Legacy Keywords
cancer, dermatology, psoriasis, lymphomacancer, dermatology, psoriasis, lymphoma
Sections
Disallow All Ads
Article PDF Media